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neuropeptide precursors yields new
insights into neuropeptide evolution
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2Institut Curie, Genetics and Biology of Cancers Unit, INSERM U830, PSL Research University, Paris 75005, France
Neuropeptides are evolutionarily ancient mediators of neuronal signalling in
nervous systems. With recent advances in genomics/transcriptomics, an
increasingly wide range of species has become accessible for molecular analy-
sis. The deuterostomian invertebrates are of particular interest in this regard
because they occupy an ‘intermediate’ position in animal phylogeny, bridging
the gap between the well-studied model protostomian invertebrates (e.g.
Drosophila melanogaster, Caenorhabditis elegans) and the vertebrates. Here we
have identified 40 neuropeptide precursors in the starfish Asterias rubens, a
deuterostomian invertebrate from the phylum Echinodermata. Importantly,
these include kisspeptin-type and melanin-concentrating hormone-type
precursors, which are the first to be discovered in a non-chordate species.
Starfish tachykinin-type, somatostatin-type, pigment-dispersing factor-
type and corticotropin-releasing hormone-type precursors are the first
to be discovered in the echinoderm/ambulacrarian clade of the animal
kingdom. Other precursors identified include vasopressin/oxytocin-type,
gonadotropin-releasing hormone-type, thyrotropin-releasing hormone-
type, calcitonin-type, cholecystokinin/gastrin-type, orexin-type, luqin-type,
pedal peptide/orcokinin-type, glycoprotein hormone-type, bursicon-type,
relaxin-type and insulin-like growth factor-type precursors. This is the most
comprehensive identification of neuropeptide precursor proteins in an echino-
derm to date, yielding new insights into the evolution of neuropeptide
signalling systems. Furthermore, these data provide a basis for experimental
analysis of neuropeptide function in the unique context of the decentralized,
pentaradial echinoderm bauplan.
1. Background
Neuropeptides are intercellular signalling molecules that are secreted by
neurons to act as neurotransmitters, modulators of synaptic transmission
or hormones. They range in size from just three amino acids, such as thyrotro-
pin-releasing hormone (TRH), to much longer polypeptides (e.g. neuropeptide
Y, which comprises 36 residues). However, all neuropeptides share the common
characteristic of being derived from larger precursor proteins, which have an N-
terminal signal peptide that targets the precursor protein to the regulated
secretory pathway. Neuropeptides are key players in neural mechanisms con-
trolling physiological and behavioural processes; for example, neuropeptides
control feeding behaviour and reproductive behaviour in vertebrates and
invertebrates [1,2]. Furthermore, the evolutionary origins of neuropeptides
as regulators of physiology and behaviour are ancient; for example, neuro-
peptide signalling pathways are key components of the nervous systems of
basal animal phyla such as the cnidarians [3], and the origins of some peptide
signalling pathways may pre-date the emergence of animals with nervous
systems [4].
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A huge variety of neuropeptides have been identified in
vertebrates and invertebrates, but establishing evolutionary
relationships between neuropeptides identified in different
phyla has proved to be quite difficult because they comprise
relatively short stretches of amino acids, typically with only a
few conserved residues. However, recent advances in com-
parative genomics/transcriptomics are transforming our
understanding of the evolutionary and functional signifi-
cance of neuropeptide diversity in animals. Thus, a core set
of neuropeptide-receptor signalling pathways have been
traced back to the common ancestor of the Bilateria, with
families of orthologous neuropeptides being identified in an
increasingly wide range of animal phyla [5,6].
The classical invertebrate model systems Drosophila mela-
nogaster and Caenorhabditis elegans have been and continue
to be important for neuropeptide research [1,2]. However,
both species belong to phyla in the ecdysozoan clade of the
animal kingdom and therefore they are not representative
of invertebrates as a whole (figure 1). Critical to recent break-
throughs in our knowledge and understanding of
neuropeptide evolution has been the analysis of genome/
transcriptome data from other invertebrates, and in particular
lophotrochozoans (annelids and molluscs) and ambulacrar-
ians (echinoderms and hemichordates) [5–10]. Thus, we are
entering a new era where we have a molecular phylogenetic
framework that enables investigation of how evolutionarily
ancient orthologous neuropeptide systems are used to regu-
late physiological and behavioural processes in animals
from a range of phyla.
The echinoderms (e.g. starfish, sea urchins, sea cucumbers)
are particularly interesting for comparative and evolutionary
studies on neuropeptide signalling systems for a variety of
reasons. They are deuterostomian invertebrates and therefore
by virtue of their close relationship with chordates (figure 1),
echinoderms can provide key insights into the evolution of
neuropeptide systems in the animal kingdom. For example,
the recent discovery of a neuropeptide precursor in the sea
urchin Strongylocentrotus purpuratus comprising multiple
copies of TRH-type peptides revealed for the first time that
the evolutionary origin of TRH-type neuropeptides extends
beyond the vertebrates to invertebrates [9]. Furthermore, echi-
noderms have the unique characteristic in the animal
kingdom of exhibiting pentaradial symmetry as adult ani-
mals, which is derived from a bilateral body plan both
evolutionarily and developmentally. Consequently, echino-
derms do not have a ‘brain’; the nervous system is
decentralized, with the control of whole-animal behaviour
co-ordinated by five radial nerve cords that are linked by a
circumoral nerve ring [11,12]. Thus, it is of interest to deter-
mine how different neuropeptide signalling systems are
organized and used to regulate physiological and behaviour-
al processes in the context of the highly derived (pentaradial)
and decentralized nervous systems of echinoderms. Relevant
to this issue, there is evidence that neuropeptides may be
involved in mediating neural control of several unusual
biological phenomena in echinoderms. The ability to autoto-
mize and then regenerate body parts is one of the most
remarkable characteristics of echinoderms and it has been
reported that arm autotomy in starfish is triggered by a
peptide(s), but its molecular identity is unknown [13].
Another unusual feature of echinoderms is the mutability
of their collagenous tissue, which can rapidly change
between stiff and soft mechanical states under the control
of the nervous system [14]. Neuropeptides that affect the stiff-
ness of the body wall in sea cucumbers have been identified
[15], but the mechanisms by which they exert effects are
unknown [16].
The first extensive analysis of neuropeptide diversity in
an echinoderm species was enabled by sequencing of the
genome and transcriptome of S. purpuratus, and 28 candidate
neuropeptide/peptide hormone precursors have been ident-
ified in this species to date [9]. These include, for example,
homologues of vasopressin (VP)/oxytocin (OT), gonado-
tropin-releasing hormone (GnRH) and calcitonin (CT). At
present, little is known about the physiological roles of
these peptides in sea urchins; however, efforts to address
this issue have commenced. For example, in vitro pharmaco-
logical studies have revealed that echinotocin, a VP/OT-type
neuropeptide, causes contraction of the oesophagus and tube
feet in sea urchins [17].
More recently, analysis of transcriptome sequence data
has identified neuropeptide/peptide hormone precursors in
a second echinoderm species, the sea cucumber Apostichopus
japonicus [10]. Thus, we now have data from species represen-
tative of two of the five classes of extant echinoderms:
Echinoidea (S. purpuratus) and Holothuroidea (A. japonicus).
Analysis of phylogenetic relationships of the extant echino-
derm classes indicates that echinoids and holothurians are
sister groups in a clade known as the Echinozoa, while aster-
oids (starfish) and ophiuroids (brittle stars) are sister groups
in a clade known as the Asterozoa, with crinoids (feather
stars and sea lilies) occupying a basal position with respect
to the echinozoa and Asterozoa [18,19]. Thus, our current
knowledge of neuropeptide diversity in echinoderms based
upon analysis of transcriptome/genome sequence data is
restricted to the echinozoan clade. Deeper insights into the
evolution and diversity of neuropeptide systems in echino-
derms could be obtained by analysis of transcriptome/
genome sequence data from asterozoans (starfish and brittle
stars) and crinoids. To begin address this issue, here we
have generated and analysed neural transcriptome data
from a species belonging the class Asteroidea—the common
European starfish Asterias rubens.
We have selected A. rubens as a model echinoderm for
transcriptomic and experimental analysis of neuropeptide
signalling systems for several reasons. First, A. rubens has
been used as an experimental system for neuropeptide
research for many years. Thus, the detection of FMRF-
amide-like immunoreactivity in the nervous system of
A. rubens led to the discovery of the first neuropeptides to
be identified in an echinoderm—the SALMFamides S1 and
S2 [20–22]. Subsequently, detailed investigations of the
expression [23–26] and pharmacological actions [26–28] of
S1 and S2 in A. rubens have provided insights into the phys-
iological roles of SALMFamides in echinoderms [29]. Second,
A. rubens is a common and therefore easily obtained species of
starfish in the UK and throughout much of coastal Europe—
the range of A. rubens extends from the White Sea in Russia to
the coast of Senegal. Asterias rubens also occurs in deeper
waters off the northern coast of North America. Furthermore,
closely related species of the genus Asterias occur globally—
Asterias forbesi along the Atlantic coast of the USA from
Maine to the Gulf of Mexico and Asterias amurensis, a Northern
Pacific starfish native to the coasts of Japan, China, Korea and
Russia (http://www.marinespecies.org/aphia.php?p=taxde-
tails&id=123776). Third, analysis of neuropeptide systems in
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A. rubens and other starfish species is also of potential interest
from an applied perspective because of the economic/environ-
mental impact of these animals as predators on shellfish
(e.g. mussels; A. rubens) [30,31] and coral (Acanthaster planci)
[32–34].
Here, we report the identification of 40 transcripts
encoding neuropeptide precursors in A. rubens based on
our analysis of neural transcriptome sequence data. Com-
bined with our recent analysis of the neuropeptide
transcriptome of the sea urchin S. purpuratus [9] and the sea
cucumber A. japonicus [10], these data provide important
new insights into the evolution and diversity of neuropeptide
signalling systems. Furthermore, the data provide a basis
for comprehensive analysis of the physiological roles of
neuropeptides in starfish, employing A. rubens as a model
experimental system.
2. Material and methods
2.1. Sequencing of Asterias rubens radial nerve
transcriptome
Radial nerve cords (approx. 30 mg) dissected from a male
adult specimen of A. rubens were used for RNA isolation
(Total RNA Isolation System, Promega). Library preparation
(TruSeqv2 kit, Illumina) was performed at the QMUL
Genome Centre and sequencing was performed on an Illu-
mina HiSeq platform at NIMR (Mill Hill), with cBot used
to generate clusters. A total of 168 776 495  100 bp reads
were obtained and raw sequence data (SRP068147; http://
www.ncbi.nlm.nih.gov/sra/SRP068147) were assembled
using SOAPDENOVO-TRANS v. 1.0 (http://soap.genomics.org.
cn/SOAPdenovo-Trans.html), a short-read assembly method
developed by the Beijing Genomics Institute [35]. Contigs
were assembled from reads with an overlap greater than
31 bp, which were then mapped back to the raw reads. The
326 816 contigs generated (with 16 316 over 1000 bp) were
then set up for BLAST analysis using SEQUENCESERVER,
which is freely available to academic users (http://www.
sequenceserver.com) [36].
2.2. BLAST-based identification of neuropeptide
precursors in Asterias rubens
To search for transcripts encoding putative neuropeptide or
peptide hormone precursor proteins in A. rubens, the
sequences of neuropeptide or peptide hormone precursors
previously identified in the sea urchin S. purpuratus
[5,6,11,16,17,37,38], the sea cucumber A. japonicus [10] and
the starfish species Asterina pectinifera [39] were submitted
individually as queries in tBLASTn searches of the contig
database with the BLAST parameter e-value set to 1000. Con-
tigs identified as encoding putative precursors were analysed
after translation of their full-length DNA sequence into
protein sequence using the ExPASy TRANSLATE tool (http://
web.expasy.org/translate/). Proteins were assessed as poten-
tial precursors of secreted bioactive peptides by investigating:
(i) the presence of a putative N-terminal signal peptide
Vertebrata
Urochordata
Cephalochordata
Hemichordata
Echinodermata
Mollusca
Annelida
Arthropoda
Nematoda
Cnidaria
deuterostom
es
protostom
es
Bilateria
Lophotrochozoa
Ecdysozoa
Ambulacraria
Chordata
Figure 1. Animal phylogeny. Phylogenetic diagram showing the position of the phylum Echinodermata (shown in red; e.g. starfish) in the deuterostomian branch of
the animal kingdom. The Bilateria comprise two super-phyla—the deuterostomes and the protostomes. The deuterostomes comprise the chordates (vertebrates,
urochordates and cephalochordates) and the ambulacrarians (hemichordates and echinoderms). The protostomes comprise the lophotrochozoans (e.g. molluscs and
annelids) and the ecdysozoans (e.g. arthropods and nematodes). The Cnidaria (e.g. sea anemones) are basal to the Bilateria. Images of representative animals from
each phylum were obtained from http://phylopic.org or were created by the authors or by M. Zandawala (Stockholm University).
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sequence, using the SIGNALP v. 3.0 online server [40], (ii) the
presence of putative monobasic or dibasic cleavage sites
N-terminal and C-terminal to the putative bioactive pep-
tide(s), with reference to known consensus cleavage motifs
[41–43], and (iii) the presence, in some cases, of a C-terminal
glycine residue that is a potential substrate for amidation.
2.3. De novo-based identification of candidate
neuropeptide precursors in Asterias rubens
A list of potential ORFs that were generated from the
A. rubens transcriptome sequence data were analysed using
a hidden Markov model described in [44,45]. The top 500
candidate sequences were then screened for the presence of
a signal peptide and short sequences flanked by canonical
Gly-Lys-Arg motifs characteristic of prohormone convertase
cleavage sites. The transcriptome sequence data were
also analysed using a novel neuropeptide-prediction tool
NpSearch, which uses characteristics of neuropeptide precur-
sors (signal peptide, dibasic cleavage sites) to identify novel
neuropeptides and their precursors (https://rubygems.org/
gems/NpSearch) [46].
2.4. Analysis of the sequences of neuropeptide
precursor transcripts identified in Asterias rubens
The protein sequences of candidate neuropeptide precursors
and polypeptide hormone precursors were annotated in
colour as follows. The N-terminal signal peptide, identified
using SIGNAlP v.3.0, was coloured blue; putative dibasic
or monobasic cleavage sites were coloured green; and the
putative neuropeptide(s) or peptide hormone(s) derived
from the precursor was coloured red, with C-terminal glycine
residues (when present) shown in orange. Figures compiling
the colour-coded precursor sequences were prepared
(figures 2, 9, 18 and 21). The DNA sequences of transcripts
encoding precursor proteins were also compiled, together
with the underlying encoded protein sequence (see electronic
supplementary material, figures S1–S40).
The sequences of A. rubens precursor proteins or the puta-
tive neuropeptides/polypeptide hormones derived from
them were aligned with homologous proteins/peptides in
other bilaterian species, some of which were identified here
for the first time. Alignments were generated and edited
using JALVIEW [47] and MAFFT [48] with JABAWS web ser-
vice [49], employing default settings (gap opening penalty
at local pairwise alignment ¼ 22, similarity matrix ¼
Blosum62, gap open penalty ¼ 1.53, group size ¼ 20, group-
to-group gap extension penalty ¼ 0.123). GENEDOC (http://
genedoc.software.informer.com) was used to annotate the
alignments and prepare alignment figures.
3. Results and discussion
By analysing A. rubens nerve cord transcriptome sequence
data, we have identified 40 candidate neuropeptide precur-
sors, which for the purposes of discussion we have divided
into four groups. First, and most interestingly, precursors of
neuropeptides that are the first members of neuropeptide
families to be identified in a non-chordate species. Second,
precursors of neuropeptides that are the first echinoderm/
ambulacrarian representatives of bilaterian neuropeptide
families to be identified. Third, precursors of neuropepti-
des that are homologues of neuropeptides that have been
identified previously in other echinoderm species and
that are members of bilaterian neuropeptide families.
Lastly, precursors of putative neuropeptides that have, as
yet, not been identified as homologues of neuropeptides in
non-echinoderm animals.
3.1. Discovery of starfish neuropeptide precursors that
provide new insights into neuropeptide evolution
at the superphylum level
3.1.1. Precursor of two kisspeptin-type peptides (ArKPP)
A kisspeptin (KP)-type neuropeptide precursor in A. rubens
(ArKPP) was identified as a 149-residue protein comprising
a predicted 24-residue N-terminal signal peptide and two
putative KP-type peptides—ArKP1 and ArKP2 (figure 2a;
GenBank: KT601705). In common with human KP, ArKP1
has a C-terminal NxxSxxLxF-NH2 motif, but unlike human
KP, ArKP1 has two cysteine residues in its N-terminal
region, which may form a disulfide bridge. ArKP2 is similar
to ArKP1 but it lacks the N-terminal pair of cysteine resi-
dues present in ArKP1 and it has additional residues in its
C-terminal region. Discovery of ArKPP is important because
it is the first KP-type precursor to be identified in a non-
chordate species, consistent with the occurrence of KP-type
receptors in non-chordates [5,6]. Furthermore, our discovery
of ArKPP facilitated identification of KP-type precursors in
other non-chordate deuterostomes, including the sea urchin
S. purpuratus (phylum Echinodermata) and the acorn worm
Saccoglossus kowalevskii (phylum Hemichordata). In figure 3,
putative KP-type peptides in these two species are aligned
with ArKP1 and ArKP2, human KP and four KP-type
peptides that have been identified previously in the cephalo-
chordate Branchiostoma floridae [5,50]. As in A. rubens, one of
the KP-type peptides in S. purpuratus has two cysteine resi-
dues, but this feature is not present in KP-type peptides in
non-echinoderm species. Therefore, the presence of a putative
N-terminal disulfide bridge may be a unique characteristic of
KP-type peptides in echinoderms.
KP or kiss1 was originally discovered in humans as a
metastasis-suppressor gene [51,52], but subsequently it was
found to have an important role in neuroendocrine control
of reproductive maturation in humans and other vertebrates
[53]. The key evidence for this was provided by the discovery
that mutations in the KP receptor (GPR54) cause delayed
puberty in humans [54,55], and the same phenotype was
observed in GPR54-knockout mice [54,56] and KP-knockout
mice [57,58]. KPs trigger hypothalamic secretion of GnRH,
which then stimulates release of gonadotropins from the pitu-
itary [59]. KP regulates the activity of GnRH neurons both
directly [60] and indirectly [61,62], and also acts directly on
gonadotropes [63]. Similarly, non-mammalian vertebrate
KP-type peptides have been implicated in the regulation of
reproductive function in several fish species [53,64,65].
At present nothing is known about the physiological roles
of KP-type peptides in invertebrates. Our discovery of a
KP-type precursor in starfish and other ambulacrarians, as
reported here, provides a basis to address this issue for the
first time.
rsob.royalsocietypublishing.org
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3.1.2. Precursor of a melanin-concentrating hormone-type
peptide (ArMCHP)
A melanin-concentrating hormone (MCH)-type neuropeptide
precursor in A. rubens (ArMCHP) was identified as an 88-
residue protein comprising a predicted 24-residue N-terminal
signal peptide and a C-terminal 28-residue MCH-type
peptide with two cysteine residues, which is preceded by
a putative dibasic cleavage site (figure 2b; GenBank:
KT601706). ArMCHP was identified on account of its
sequence similarity with Spnp14, a putative neuropeptide
precursor in the sea urchin S. purpuratus [9]. However, com-
parison of ArMCHP with vertebrate neuropeptides revealed
sequence similarity with MCH-type peptides, as illustrated
in figure 4. Furthermore, the location of the putative neuro-
peptide ArMCH in the C-terminal region of ArMCHP is
likewise a characteristic of MCH-type precursors in ver-
tebrates, providing further evidence of orthology [66].
Interestingly, identification of ArMCHP also facilitated
identification of a MCH-type precursor in a hemichordate
species, the acorn worm S. kowalevskii (figure 4).
Our discovery of MCH-type peptides in echinoderms and
hemichordates is important because these are the first MCH-
type neuropeptides to be discovered in invertebrates. Align-
ment of the invertebrate and vertebrate MCH-type peptides
reveals a conserved pair of cysteine residues. These residues
form a disulfide bridge in vertebrate MCH-type peptides
[67] and therefore it is likely that invertebrate MCH-type
peptides also have a disulfide bridge. Other conserved fea-
tures include a methionine (or isoleucine) residue following
the first cysteine residue and a basic amino acid (lysine or
arginine) penultimate to the second cysteine residue. Interest-
ingly, the number of residues that separate the two cysteine
residues is greater in the invertebrate MCH-type pepti-
des than in vertebrate MCH-type peptides, with two
additional residues (DW or DV) located after the conserved
methionine/isoleucine residue.
MCH was first identified in teleost fish on account of its
effect in triggering a change in body colour [68,69]. Sub-
sequently, MCH-type peptides were identified throughout
the vertebrates [70–72], and experimental studies have
revealed a wide range of physiological roles, including regu-
lation of feeding, sleep and reproduction [73,74]. Our
discovery of MCH-type peptides in ambulacrarians provides
a unique opportunity to investigate for the first time the
actions of these peptides in invertebrates and the evolution
of the physiological roles of this family of neuropeptides.
3.2. Discovery of the first ambulacrarian/echinoderm
representatives of bilaterian neuropeptide families
3.2.1. Precursor of two tachykinin-type peptides (ArTKP)
A tachykinin (TK)-type neuropeptide precursor in A. rubens
(ArTKP) was identified as a 199-residue protein comprising
a predicted 31-residue N-terminal signal peptide and two
putative TK-type neuropeptides, ArTK1 and ArTK2, which
are bounded by putative monobasic or dibasic cleavage
sites (figure 2c; GenBank: KT601707). The presence of
C-terminal glycine residues is indicative of post-translational
conversion to amide groups in the mature peptides, and the
presence of an N-terminal glutamine residue in ArTK1 is
indicative of potential post-translational conversion to a pyr-
oglutamate residue. ArTKP was identified because it has the
characteristics of a neuropeptide precursor, and comparison
of its sequence with bilaterian neuropeptide precursors
revealed similarity with TK-type precursors. In particular,
alignment of ArTK1 and ArTK2 with TK-type peptides in
Figure 2. Precursors of neuropeptides in A. rubens that provide novel insights into neuropeptide evolution at the superphylum/phylum level. Predicted signal
peptides are shown in blue, putative neuropeptides are shown in red (with cysteine (C) residues underlined), C-terminal glycine (G) residues that are putative
substrates for amidation are shown in orange and putative dibasic/tribasic cleavage sites are shown in green.
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chordates reveals a conserved C-terminal GLXamide motif
(figure 5).
TK-type peptides are a family of neuropeptides with a
widespread phylogenetic distribution indicative of an ances-
tral bilaterian origin [5,6]. ArTK1 and ArTK2 are the first
members of the TK-type neuropeptide family to be identified
in an echinoderm and, more broadly, an ambulacrarian. Ver-
tebrate TK-type peptides share the conserved C-terminal
pentapeptide motif FxGLM-NH2, whereas TK-type peptides
in protostomian invertebrates typically share the conserved
C-terminal pentapeptide motif FxGxR-NH2 (figure 5). ArTK1
and ArTK2 have the C-terminal pentapeptide motifs QSGLF-
NH2 and QSGGIF-NH2, respectively, which share the
common motif GxF-NH2, with x representing a hydrophobic
leucine or isoleucine residue, and in this respect ArTK1 and
ArTK2 are similar to vertebrate TK-type peptides (figure 5).
Conversely, a conserved feature of TK-type peptides that is
not present in the starfish peptides is a phenylalanine residue
at the fifth position from the C-terminal amide.
The first TK-type peptide to be discovered was the mam-
malian neuropeptide substance P (SP) [75–77]. Subsequently,
two other TKs were discovered in mammals—neurokinin A
(NKA) and neurokinin B (NKB) [78–80]. TK-type peptides
act as neurotransmitters, neuromodulators and neurohor-
mones in both the central and peripheral nervous system of
mammals, with roles in regulation of, for example, intestinal
motility [81], smooth muscle contraction [82] and cardiovas-
cular function [83]. TK-type peptides have also been
identified in non-mammalian vertebrates [84], in urochor-
dates [85] and in protostomian invertebrates, including
molluscs [86,87], annelids [88,89], arthropods [90–93] and
nematodes [94]. Investigation of the physiological roles of
TK-type peptides in protostomes has revealed, for example,
effects on gut/oviduct motility and lipid synthesis in insects
and rhythmic motor output of the somatogastric system in
crustaceans [90,95–97]. Now with the discovery of ArTK1
and ArTK2 in A. rubens, as reported here, an opportunity
to investigate for the first time the physiological roles of
TK-type neuropeptides in an echinoderm has been provided.
3.2.2. Precursor of a somatostatin-type peptide (ArSSP)
A somatostatin (SS)-type neuropeptide precursor in A. rubens
(ArSSP) was identified as a 132-residue protein comprising
a predicted 24-residue N-terminal signal peptide and a
13-residue SS-type peptide that is preceded N-terminally
by a putative dibasic cleavage site (figure 2d; GenBank:
KT601708). ArSSP was identified based on its sequence simi-
larity with Spnp19, a putative neuropeptide precursor
previously identified in the sea urchin S. purpuratus [9]. How-
ever, comparison of ArSSP and Spnp19 (SpSSP) with known
neuropeptide precursors revealed similarity with vertebrate
SS/cortistatin-type precursors. For example, both ArSS and
SpSS share a CxxxFxxxxxxC motif with human SS and cortis-
tatin (figure 6). In vertebrate SS/cortistatin-type peptides, the
two cysteine residues form an intramolecular disulfide bridge
[98], and therefore it is likely that the same post-translational
modification occurs in the starfish and sea urchin SS-type
peptides. Furthermore, as with ArMCHP, another feature
of ArSSP that suggests homology with vertebrate SS-type
precursors is the conserved location of an SS-type neuro-
peptide at the C-terminus of the precursor [99]. The
discovery of SS-type neuropeptides in starfish and sea urchins
is important because these are the first to be identified in
echinoderms and they join a bilaterian family of neuropeptides
that include allatostatins in arthropods [5,6,100].
SS was first isolated from sheep hypothalamus [101], and
was initially characterized as a neuroendocrine peptide that
inhibits release of pituitary hormones such as growth
hormone and prolactin [102,103]. Subsequently, an SS-type
peptide termed cortistatin was discovered in humans [104]
and has since been found to occur throughout the tetrapod
vertebrates [99]. Additional SS-type peptides are present in
teleost fish [105], and a candidate SS-type peptide was
recently identified in the cephalochordate B. floridae
(figure 6) [5]. In addition to its effects on pituitary hormone
release, SS also has central actions that influence motor
activity, sensory processing and cognition [106].
Allatostatins inhibit juvenile hormone (JH) biosynthesis in
the corpora allata of insects and three structurally unrelated
types of allatostatins have been identified. Allatostatins were
first isolated from the cockroach Diploptera punctata and
these are now referred to as allatostatin-A [107–109], while
neuropeptides with allatostatic activity that were originally
identified from the cricket Gryllus bimaculatus are referred to
as allatostatin-B [110]. The allatostatin-C (AST-C)-type pep-
tides that are related to vertebrate SSs were first identified
in the tobacco hornworm Manduca sexta [111], but have
subsequently been identified in a number of arthropods,
including numerous insect species [100,112–115].
Figure 3. Alignment of ArKP1 and ArKP2 with other kisspeptin (KP)-type peptides. Accession numbers for the corresponding precursor proteins are: Arub, A. rubens
KP-type precursor [GenBank: KT601705]; Spur, S. purpuratus KP-type precursor [GI:374768013]; Skow, S. kowalevskii KP-type precursor [GI:187123982]; Bflo1, B.
floridae KP-type precursor 1 [GI:260826607]; Bflo2, B. floridae KP-type precursor 2 [GI:260827077]; Bflo3, B. floridae KP-type precursor 3 [GI:260826605]; Bflo4,
B. floridae KP-type precursor 4 [GI:260793233]; Hsap, Homo sapiens KiSS-1 metastasis-suppressor precursor [GI:21950713].
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Our discovery of precursors of SS-type neuropeptides in
echinoderms is important because it provides a basis for
investigation of their physiological roles in non-chordate deu-
terostomes. A common theme that emerges from comparison
of the actions of SS-type and AST-C-type neuropeptides in
vertebrates and insects, respectively, is their roles in inhibi-
tory regulation of the biosynthesis/release of hormones that
regulate development and growth. Against this background,
it will be of great interest to discover the physiological roles of
SS-type neuropeptides in echinoderms.
3.2.3. Precursor of two pigment-dispersing factor-type peptides
(ArPDFP)
A pigment-dispersing factor (PDF)-type neuropeptide
precursor in A. rubens (ArPDFP) was identified as a 104-
residue protein comprising a predicted 22-residue N-terminal
signal peptide and two putative PDF-type neuropeptides
bounded by dibasic/tribasic cleavage sites: ArPDF1, a 35-
residue polypeptide with a C-terminal glycine residue that
may be a substrate for amidation, and ArPDF2, a 29-residue
polypeptide (figure 2e; GenBank: KT601709). ArPDFP was
identified on account of its sequence similarity with a protein
in the sea urchin S. purpuratus, which was reported pre-
viously as a corticotropin-releasing hormone (CRH)-type
neuropeptide precursor [6]. However, three observations
lead us to conclude that ArPDFP is, as its name implies, a
PDF-type precursor. First, the A. rubens and S. purpuratus
PDF-type peptides share sequence similarity with a PDF-
type peptide that was identified recently in the hemichordate
S. kowalevskii [5] and with PDF/cerebrin-type peptides in pro-
tostomian invertebrates, as illustrated in figure 7. Second, the
occurrence of two putative neuropeptides in ArPDFP is a fea-
ture that is also seen other PDF-type precursors [116] but not
in CRH-type precursors. Third, we have identified other
neuropeptide precursors in A. rubens and the sea urchin S.
purpuratus that exhibit a higher level of similarity with
CRH-type precursors (see below).
PDF or pigment-dispersing hormone was first identified
in crustacean species on account of its effect in causing pig-
ment migration in retinal pigment cells of the eyes [117].
Subsequently, PDF-type peptides were identified in other
arthropods [118], and experimental studies on Drosophila
revealed that PDF released by sub-populations of neurons
in the brain is required for normal circadian patterns of loco-
motor activity [119–121]. PDF-type peptides have also been
identified in nematodes [122] and lophotrochozoans, includ-
ing molluscs [7] and annelids [8]. PDF-type neuropeptide
signalling in the nematode C. elegans regulates locomotor
activity and egg-laying [123], while a PDF-type neuropeptide
in the mollusc Aplysia californica (‘cerebrin’) affects the feed-
ing motor pattern, mimicking the motor-pattern alterations
observed in food-induced arousal states [124].
Phylogenetic studies indicate that PDF-type peptides are
a bilaterian neuropeptide family that has been lost in the
chordate lineage [5,6]. Therefore, the discovery of PDF-type
neuropeptides in echinoderms, as reported here, and in hemi-
chordates [5] is of particular interest because it provides a
unique opportunity for the first investigations of the physiologi-
cal roles of this family of neuropeptides in deuterostomian
invertebrates.
3.2.4. Precursor of a corticotropin-releasing hormone-type
peptide (ArCRHP)
A CRH-type neuropeptide precursor in A. rubens (ArCRHP)
was identified as a 130-residue protein comprising a
predicted 28-residue N-terminal signal peptide and a 41-
residue CRH-type peptide sequence bounded by dibasic/
tribasic cleavage sites (figure 2f; GenBank: KT601710). An
N-terminal glutamine residue and a C-terminal glycine resi-
due may be substrates for post-translational modifications
that give rise to an N-terminal pyroglutamate residue and a
C-terminal amide group in themature peptide. As highlighted
above, neuropeptides in echinoderms purported to be CRH-
type peptides have been reported previously [5,6,10], but
further analysis here has revealed that these are in fact PDF-
type peptides. Therefore, ArCRHP is the first bone fide CRH-
type precursor to be identified in an echinoderm. Previous
studies have identifiedCRH-typeprecursors in other deuteros-
tomian invertebrates, including the hemichordateS. kowalevskii
[5,6] and the cephalochordate B. floridae [5], and in figure 8
we show an alignment of the A. rubens CRH-type peptide
(ArCRH) with homologues from these two species, human
CRH/urocortin-type peptides and CRH-type peptides in
lophotrochozoan protostomes. The alignment highlights
several residues that are conserved at the interphyletic level.
CRH was first identified as a hypothalamic neurohor-
mone that stimulates release of adrenocorticotropic
Figure 4. Alignment of ArMCH with other melanin-concentration hormone
(MCH)-type peptides. Accession numbers for the corresponding precursor pro-
teins are: Arub, A. rubens MCH-type precursor [GenBank: KT601706]; Spur, S.
purpuratus MCH-type precursor [GI:109402760]; Skow, S. kowalevskii MCH-
type precursor [GI:187231810]; Trub, Takifugu rubripes MCH precursor
[GI:410918650]; Hsap, H. sapiens MCH precursor [GI:187445]. Figure 5. Alignment of ArTK1 and ArTK2 with other tachykinin (TK)-type pep-
tides. Accession numbers for the corresponding precursor proteins are: Arub,
A. rubens TK-type precursor [GenBank: KT601707]; Spur, S. purpuratus TK-type pre-
cursor [GI:109402899]; Cint, C. intestinalis TK-type precursor [GI:74136064];
Hsap_SubP, H. sapiens b-prepro TK precursor [GI:29482]; Hsap_NKB, H. sapiens
neurokinin-b precursor [GI:48146502]; Hsap_NKA, H. sapiens TK4 precursor
[GI:117938255]; Ctel, Capitella teleta [GI:161289578]; Lgig1, Lottia gigantea TK-
type precursor 1 [GI:676441944]; Lgig2, L. gigantea TK-type precursor 2
[GI:163525452]; Dmel, D. melanogaster TK precursor [GI:442618676].
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hormone in response to stress in mammals [125,126]. CRH-
type peptides have also been identified in non-mammalian
vertebrates, and in addition to its corticotropic effect, CRH
acts as a thyrotropic hormone [127]. A CRH-type peptide in
insects, DH44, acts as a diuretic hormone, stimulating fluid
secretion by Malpighian tubules by elevating cAMP levels
[128]. In the mollusc Aplysia, egg-laying hormone (ELH) is
a CRH-type peptide [129,130] and ELH/CRH-type peptides
have subsequently been identified in other molluscan species
[131]. It has also been reported that ELH-type peptides
trigger gamete release in annelids [132]. Against this
backdrop of diverse physiological roles, the discovery of
CRH-type peptides in starfish and other deuterostomian
invertebrates provides a unique opportunity to obtain new
insights into the evolution of the physiological roles of
CRH-type neuropeptides in the animal kingdom.
3.3. Discovery of novel starfish representatives of
bilaterian neuropeptide and peptide hormone
families
3.3.1. Precursor of a vasopressin/oxytocin-type neuropeptide
(asterotocin)
AVP/OT-type neuropeptide precursor in A. rubenswas ident-
ified as a 147-residue protein comprising a predicted 23-residue
N-terminal signal peptide, a VP/OT-type neuropeptide
sequence (CLVQDCPEGG) followed by a dibasic cleavage site
and a neurophysin domain (figure 9a; GenBank: KT601711).
This structure of the precursor conforms to the evolutionarily
conserved organization of VP/OT-type neuropeptide precur-
sors throughout the Bilateria [5,133]. Mature VP/OT-type
neuropeptides are typically C-terminally amidated and have a
disulfide bridge between two highly conserved cysteine resi-
dues, which are crucial for biological activity [134–136].
Therefore, the predicted neuropeptide product of the VP/OT-
type precursor inA. rubens is CLVQDCPEG-NH2, with a disul-
fide bridge between the two cysteine residues. We refer to this
putative starfish VP/OT-type neuropeptide as ‘asterotocin’, in
keeping with the naming of a VP/OT-type peptide,
‘echinotocin’, which was identified previously in the echinoid
(sea urchin) S. purpuratus [17].
In figure 10, we have compared the sequence of asteroto-
cin with VP/OT-type neuropeptides that have been identified
in other animals. The presence in asterotocin of leucine and
valine residues at positions 2 and 3, respectively, is atypical
for VP/OT-type peptides but consistent with the occurrence
of hydrophobic residues at these positions in other VP/OT-
type peptides. The aspartic acid at position 5 in asterotocin
is also atypical (more commonly it is an asparagine), but
this feature is also seen in several other VP/OT-type pep-
tides, including peptides identified in the hemichordate
S. kowalevskii, the urochordates Ciona intestinalis and Styela pli-
cata [137,138], and the nematode C. elegans [139]. The most
unusual and interesting structural characteristic of asterotocin
is the presence of a glutamate residue at position 8 because, to
the best of our knowledge, this is the first of example of a
VP/OT-type neuropeptide with an acidic residue in this pos-
ition. Typically, the residue in this position is a basic residue
(e.g. lysine or arginine in mammalian VPs) or a hydrophobic
residue (e.g. leucine in OT). Furthermore, this feature of aster-
otocin may be unique to starfish or a sub-set of echinoderms
because the VP/OT-type neuropeptide previously identified
in the sea urchin S. purpuratus (echinotocin; CFISNCPKG-
NH2) has a lysine residue at position 8 [17]. Therefore, it
may be of interest to investigate the importance of the chemi-
cal characteristics of the amino acid at position 8 for the
biological activity of asterotocin.
VP was first discovered in mammals on account of its
effects as a regulator of blood pressure and diuresis
[140,141], while OT was discovered on account of its effects
as a stimulator of uterine contraction and lactation [142].
However, in addition to these peripheral hormonal functions,
VP and OT also have central neuromodulatory roles in social
cognition and behaviour, including mother–infant bonding
[143], and pair bonding and attachment [144,145]. Currently,
there is great interest in both VP and OT with respect to
understanding human social behaviour and neuropathology,
with implications of involvement in disorders such as autism,
social anxiety disorder, borderline personality disorder and
schizophrenia [146,147].
As illustrated in figure 10, VP/OT-type neuropeptides
have a widespread phylogenetic distribution indicative of
an evolutionary origin dating back to the common ancestor
of bilaterians [5,6]. VP/OT-type peptides have been identified
in many vertebrate species [148,149] and in deuterostomian
Figure 6. Alignment of ArSS with other somatostatin (SS)-type peptides and
AST-C-type peptides. Accession numbers for the corresponding precursor proteins
are: Arub, A. rubens SS-type precursor [GenBank: KT601708]; Spur, S. purpuratus
SS-type precursor [GI:390344260]; Bflo, B. floridae SS-type precursor [JGI:72051];
Hsap_SS, H. sapiens SS precursor [GI:21619155]; Hsap_CORT, H. sapiens cortis-
tatin (CORT) precursor [GI:110645815]; Ctel, C. teleta AST-C-type precursor
[GI:161295377]; Lgig, L. gigantea AST-C-type precursor [GI:163505903]; Dme-
l_AstC, D. melanogaster AST-C-type precursor [GI:665407583]; Dmel_AstCC,
D. melanogaster AST-CC-type precursor [GI:665407585].
Figure 7. Alignment of ArPDF1 and ArPDF2 with other pigment-dispersing
factor (PDF)-type peptides. Accession numbers for the corresponding precursor
proteins are: Arub, A. rubens PDF-type precursor [GenBank: KT601709]; Spur,
S. purpuratus PDF-type precursor [GI:115899431]; Skow, S. kowalevskii PDF-type
precursor [GI:187067819]; Ctel, C. teleta PDF-type precursor [JGI:204689]; Lgig,
L. gigantea cerebrin precursor [GI:676458325]; Dmel, D. melanogaster PDF
precursor [GI:281362639]; Cele, C. elegans PDF precursor [GI:25149644].
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invertebrates, including the urochordates [137,138], the
cephalochordate B. floridae [150], the hemichordate S. kowa-
levskii [151] and the echinoderm S. purpuratus [17]. VP/
OT-type peptides have also been identified in protostomes
[152–154]. Furthermore, recent studies on the nematode
C. elegans have shown that the VP/OT-type peptide nemato-
cin [139,155] is involved in gustatory associative learning and
control of mating behaviour in this species [1,139]. It has
therefore been hypothesized that VP/OT-type peptides may
be ancient modulators of reproductive behaviour and
associative learning [1].
Currently, little is known about the physiological roles of
VP/OT-type neuropeptides in echinoderms. In vitro pharma-
cological tests have, however, revealed that echinotocin
causes contraction of tube foot and oesophagus preparations
in the sea urchin species Echinus esculentus [17]. These effects
of echinotocin are consistent with contractile actions of VP
and OT on blood vessels and uterus, respectively, in mam-
mals [140–142]. Likewise, a VP/OT-type neuropeptide
causes contraction of the inhalant and exhalant siphons in
the urochordate S. plicata [138]. With the discovery of the
asterotocin precursor in A. rubens, as reported here, an oppor-
tunity to investigate the physiological roles of a VP/OT-type
neuropeptide in starfish has been provided.
3.3.2. Precursor of NGFFYamide, a neuropeptide-S/NG peptide/
crustacean cardioactive peptide-type neuropeptide
Discovery of the A. rubens NGFFYamide precursor was
reported recently [156] and was accomplished by analysis
of the same neural transcriptome dataset analysed here;
therefore, it is included here for sake of completeness. The
NGFFYamide precursor is a 239-residue protein comprising
a predicted 23-residue N-terminal signal peptide, two
copies of the sequence NGFFYG bounded by dibasic clea-
vage sites and a C-terminal neurophysin domain containing
14 cysteine residues (figure 9b; GenBank: KC977457), which
is a conserved feature of neurophysins. Post-translational con-
version of the C-terminal glycine residue of the NGFFYG
peptide to an amide group has been confirmed by mass
spectrometry [156].
NGFFYamide belongs to a bilaterian family of neuro-
peptides that include the vertebrate peptide neuropeptide-
S (NPS), protostomian crustacean cardioactive peptide
(CCAP)-type neuropeptides and NG peptides, neurophysin-
associated peptides in deuterostomian invertebrates that are
characterized by an Asn-Gly (NG) motif, which include
NGFFYamide. This relationship of NG peptides with NPS/
CCAP-type peptides was proved recently with the discovery
that the NG peptide NGFFFamide is the ligand for an NPS/
CCAP-type receptor in the sea urchin S. purpuratus [157]. Fur-
thermore, the presence of a neurophysin domain in NG
peptide precursors reflects a common ancestry with VP/
OT-type precursors, with gene duplication in a common
ancestor of the Bilateria having given rise to the VP/OT-
type and the NPS/NG peptide/CCAP-type neuropeptide
signalling systems [5,157].
NPS acts as an anxiolytic in mammals and induces wake-
fulness and hyperactivity [158], whereas CCAP activates the
ecdysis motor programme in arthropods that results in shed-
ding of the exoskeleton [159,160]. Thus, a common theme for
these neuropeptides appears to be roles in behavioural states
associated with a heightened state of arousal [157]. We
have investigated the physiological roles of NGFFYamide in
A. rubens and have discovered that it potently stimulates con-
traction of the cardiac stomach in vitro [156]. Starfish feed by
everting their cardiac stomach over the digestible parts of
prey such as mussels and in vivo pharmacological tests have
revealed that NGFFYamide triggers retraction of the everted
cardiac stomach [156]. Therefore, it is likely that NGFFY
amide acts physiologically to mediate neural control of
cardiac stomach retraction in starfish.
3.3.3. Precursor of gonadotropin-releasing hormone-type
peptide 1 (ArGnRH1P)
A GnRH-type neuropeptide precursor in A. rubens
(ArGnRH1P) was identified as a 121-residue protein com-
prising a predicted 27-residue N-terminal signal peptide
Figure 8. Alignment of ArCRH with other corticotropin-releasing hormone (CRH)-type peptides. Accession numbers for the corresponding precursor proteins are:
Arub, A. rubens CRH-type precursor [GenBank: KT601710]; Skow1, S. kowalevskii CRH-type precursor 1 [GI:281433636]; Skow2, S. kowalevskii CRH-type precursor 2
[GI:281433636]; Bflo, B. floridae CRH-type precursor [GI:260786674]; Hsap_CRH, H. sapiens CRH precursor [GI:30583744]; Hsap_UCN, H. sapiens urocortin (UCN)
precursor [GI:49457481]; Hsap_UCN2, H. sapiens stresscopin-related protein precursor [GI:14029393]; Hsap_UCN3, H. sapiens stresscopin precursor [GI:15026913];
Ctel1, C. teleta CRH-type precursor 1 [GI:161303031]; Ctel2, C. teleta CRH-type precursor 2 [JGI:190906]; Ctel3, C. teleta CRH-type precursor 3 [JGI:190906]; Ctel4,
C. teleta CRH-type precursor 4 [JGI:194553]; Lgig1, L. gigantea CRH-type precursor 1 [GI:676493124]; Lgig2, L. gigantea CRH-type precursor 2 [GI:163524672].
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and a GnRH-type peptide sequence (QIHYKNPGWGPG)
followed by a dibasic cleavage site (figure 9c; GenBank:
KT601712). The presence of an N-terminal glutamine residue
and a C-terminal glycine residue are indicative of post-
translational modifications giving rise to an N-terminal
pyroglutamate residue and a C-terminal amide group in
the putative mature peptide (pQIHYKNPGWGPG-NH2;
ArGnRH1), which would be consistent with GnRH-
type neuropeptides that have been identified in other
species [161].
GnRH-type peptides have a widespread phylogenetic dis-
tribution indicative of an evolutionary origin dating back to
the common ancestor of bilaterians [5,6]. The structural
organization of ArGnRH1P conforms to other GnRH-type
precursor proteins, with a single GnRH-type peptide located
directly after the N-terminal signal peptide (figure 9c).
Furthermore, comparison of the sequence of ArGnRH1 with
other GnRH-type peptides reveals several conserved features,
including the aforementioned predicted N-terminal pyrogluta-
mate and C-terminal amide as well as a GWxP motif at
positions 8–11 in ArGnRH1 (figure 11a). The C-terminal PG
motif in ArGnRH1 is a feature that it shares with human
GnRHs.
GnRH was first discovered in mammals as a reproductive
regulator through its stimulatory effect on the release of the
gonadotropins luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) from the anterior pituitary
gland [162]. GnRH-type peptides have subsequently been
identified in other vertebrates [163,164] and deuterostomian
invertebrates, including urochordates [165,166], the cephalo-
chordate B. floridae [167], the hemichordate S. kowalevskii [5]
and the echinoderm S. purpuratus [9]. GnRH-type peptides
Figure 9. Precursors of neuropeptides in A. rubens that are novel echinoderm representatives of bilaterian neuropeptide families. Predicted signal peptides are
shown in blue, putative neuropeptides are shown in red (with cysteine (C) residues underlined), C-terminal glycine (G) residues that are putative substrates
for amidation are shown in orange and putative dibasic cleavage sites are shown in green. For the (a) asterotocin and (b) NGFFYamide precursors, the C-terminal
neurophysin domain (with the characteristic 14 cysteine (c) residues underlined) is shown in purple.
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have also been identified in lophotrochozoans, including sev-
eral molluscan species [168–170] and annelids [8,161,169].
Interestingly, it has been discovered that adipokinetic
hormone (AKH) in the ecdysozoans (arthropods and nema-
todes) and corazonin (CORZ)-type peptides and AKH/
CORZ-related peptides (ACP) in the arthropods are homol-
ogues of GnRH [171–173]. In insects, AKH is synthesized
in the corpora cardiaca, which are functionally equivalent
to the pituitary gland in vertebrates, and acts to mobilize
energy from the fat body during flight and locomotion
[174,175]. AKH-type peptides in the nematode C. elegans
regulate fertility, indicating that GnRH/AKH-type peptides
have an evolutionarily ancient role in neural control of re-
productive processes [171]. The physiological roles of
GnRH-type peptides in echinoderms are currently unknown.
Therefore, the discovery of ArGnRH1 in A. rubens, as
reported here, provides an opportunity to address this issue.
3.3.4. Precursor of gonadotropin-releasing hormone-type
peptide 2 (ArGnRH2P)
A second GnRH-type neuropeptide precursor in A. rubens
(ArGnRHP2) was identified as a 99-residue protein compris-
ing a predicted 23-residue N-terminal signal peptide and a
putative GnRH-type peptide sequence (HNTFTMGGQN
RWKAGG) followed by a dibasic cleavage site (figure 9d;
GenBank: KT601713). The presence of a C-terminal glycine
residue is indicative of a post-translational modification that
gives rise to a C-terminal amide group on the mature peptide
(HNTFTMGGQNRWKAG-NH2). However, the absence of an
N-terminal pyroglutamate residue is atypical for GnRH-type
neuropeptides [161].
ArGnRHP2 was identified on account of its sequence
similarity with Spnp12, a putative neuropeptide precursor
previously identified in the sea urchin S. purpuratus [9]. How-
ever, here we have discovered that the structural organization
and sequence of Spnp12 and its homologue in A. rubens are
similar to GnRH-type precursors in S. purpuratus, A. rubens
(figure 11b) and other species. Thus, the GnRH-type peptide
is located directly following the signal peptide, and
ArGnRH1P and ArGnRH2P have a conserved C-terminal
domain. Furthermore, ArGnRH2 shares a C-terminal
WxxG-NH2 motif with ArGnRH1 (figure 11b).
Investigation into the evolution of GnRH-type neuropep-
tide signalling systems in the Bilateria has revealed a complex
picture [167]. A variety of neuropeptide types, including
chordate GnRH-type peptides, arthropod AKH-type, CORZ
and ACP-type peptides, appear to have evolved from a
common ancestral peptide that occurred in the common
ancestor of the Bilateria. However, the timing of the gene
duplications that gave rise to this heterogeneous family of
neuropeptides that occur in extant bilaterians remains
unclear. Discovery of a second GnRH-type neuropeptide pre-
cursor in echinoderms (starfish and sea urchins) adds further
complexity. However, our findings provide a basis for func-
tional characterization of ArGnRH1 and ArGnRH2, which
may provide new insights that facilitate a deeper understand-
ing of the evolution of GnRH-type signalling systems in the
Bilateria.
3.3.5. Precursor of thyrotropin-releasing hormone (TRH)-type
peptides (ArTRHP)
A TRH-type neuropeptide precursor in A. rubens (ArTRHP)
was identified as a 225-residue protein comprising a predicted
23-residue N-terminal signal peptide and 12 putative TRH-
type peptides bounded by dibasic cleavage sites (figure 9e;
GenBank: KT601714). These include a single copy of the pep-
tide sequence QYPGGAPIGLDG and 11 copies of the peptide
sequence QWYTG. The presence of an N-terminal glutamine
residue and a C-terminal glycine residue in these peptide
sequences are indicative of potential post-translational modifi-
cation to an N-terminal pyroglutamate and a C-terminal
amide group in the mature peptides, which would be consist-
ent with the structure of TRH in mammals (pQHP-NH2).
Hence the predicted structure of the multi-copy TRH-type
peptide in A. rubens is pQWYT-NH2. Furthermore, the occur-
rence of multiple copies of this peptide is consistent with the
organization of TRH-type precursors in vertebrates, which
comprise multiple copies of TRH [176,177].
Comparison of ArTRHP with TRH-type precursors that
have been identified in other echinoderm species reveals simi-
larities. TRH-type precursors in the sea urchin S. purpuratus [9]
and in the sea cucumber A. japonicus [10] comprise 19
putative neuropeptides. The most abundant predicted neuro-
peptide product of the S. purpuratus precursor is pQYPG-
NH2 and the most abundant predicted neuropeptide product
of the A. japonicus precursor is pQYFA-NH2. Thus, with our
discovery of the putative pQWYT-NH2 peptide in A. rubens,
it appears that a tetrapeptide with an N-terminal pyrogluta-
mate and a C-terminal amide are conserved features of
TRH-type peptides in echinoderms, which contrasts with
the tripeptidic TRH-type peptides that occur in chordates,
namely pQHP-NH2 in vertebrates and pQSP-NH2 in the
cephalochordate B. floridae (figure 12). Comparison of the
sequences of the most abundant of the TRH-type peptides
in the three echinoderm species reveals similarities, with
the amino acids in positions 2 and 3 having side chains that
are aromatic (Y, F or W) or cyclic (P) (figure 12). In this
respect, there is similarity with TRH in vertebrates, which
has an aromatic histidine residue in position 2 and a cyclic
proline residue in position 3 (figure 12).
TRH was first identified in mammals as a hypothalamic
peptide that stimulates the release of the hormones thyroid-
stimulating hormone (TSH) and prolactin from the anterior
pituitary gland. Release of TSH then triggers release of
Figure 10. Alignment of asterotocin with other vasopressin/oxytocin (VP/OT)-
type peptides. Accession numbers for the corresponding precursor proteins are:
Arub, A. rubens asterotocin precursor [GenBank: KT601711], Spur, S. purpuratus
echinotocin precursor [GI:390337108]; Skow, S. kowalevskii VP/OT-type precursor
[GI:187155721]; Bflo, B. floridae VP/OT-type precursor [GI:260828088];
Hsap_VP, H. sapiens VP precursor [GI:340298]; Hsap_OT, H. sapiens OT precur-
sor [GI:189410]; Ctel, C. teleta VP/OT-type precursor [JGI:173251]; Lgig,
L. gigantea VP/OT-type precursor [JGI:53893]; Dpul, Daphnia pulex VP/OT-
type precursor [JGI:59567].
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thyroid hormones (T3 and T4) that stimulate metabolism
in cells throughout the body and promote growth and
development [125]. TRH also acts as neurotransmitter or
neuromodulator in other regions of the brain [178,179]. In
amphibians and fish, TRH stimulates the release of pituitary
growth hormone and prolactin but has little or no effect on
the secretion of TSH [180]. Thus, the role of TRH as a regula-
tor of TSH release in mammals does not apply to all
vertebrate species.
The occurrence of TRH-type receptors in deuterostomes
and protostomes indicates that the evolutionary origin of
this neuropeptide signalling system dates back to the
common ancestor of the Bilateria [5,6]. In support of this,
FSEFLGamide has recently been discovered as the ligand
for a TRH-type receptor in the annelid Platynereis dumerilii
[181]. It has therefore been proposed that the ‘EFLGamides’
identified in the lophotrochozoans [182] are orthologous to
deuterostomian TRH-type neuropeptides [181]. The charac-
terization of the P. dumerilii TRH-type receptor highlights
the importance of receptor orthology in determining relation-
ships between neuropeptides in distantly related phyla
that share modest sequence similarity. The discovery of
TRH-type peptides in echinoderms [9,10], including the star-
fish A. rubens (this paper), and in the cephalochordate
B. floridae [6] has provided opportunities to investigate for
the first time the physiological roles of TRH-type peptides
in deuterostomian invertebrates.
3.3.6. Precursor of a calcitonin-type peptide (ArCTP)
A CT-type neuropeptide precursor in A. rubens (ArCTP) was
identified as a 114-residue protein comprising a predic-
ted 21-residue N-terminal signal peptide and a 40-residue
CT-type peptide sequence bounded by dibasic cleavage
sites (figure 9f; Gen Bank: KT601715). The presence of a
C-terminal glycine residue is indicative of a post-translational
modification that gives rise to a C-terminal amide group on
the mature peptide, which would be consistent with CT-
type neuropeptides that have been identified in other species.
The putative CT-type peptide (ArCT) contains two cysteine
residues in the N-terminal region, which may form an intra-
molecular disulfide bridge in accordance with other CT-type
peptides [182,183].
ArCT is the third CT-type neuropeptide to be identified
in an echinoderm, following the identification of CT-type
peptides in the sea urchin S. purpuratus [9] and the sea
cucumber A. japonicus [10]. In figure 13, we show an align-
ment of ArCT with CT-type peptides that have been
identified in other deuterostomes and in lophotrochozoans,
which also illustrates the antiquity of this bilaterian
neuropeptide family. A conserved feature of these neuro-
peptides is the presence of the two cysteine residues in the
N-terminal region, which—as highlighted above—form a
disulfide bridge. Another conserved feature is a C-terminal
amidated proline, although this character has been lost in
some CT-type peptides that occur in vertebrates, such as
CT-gene-related peptide (CGRP), islet amyloid polypeptide
(IAPP) and adrenomedullins (figure 13).
CT-type peptides have also been identified in insects and
other arthropods, and were discovered on account of their
effects as diuretic hormones (DH31) [184]. However, the
DH31-type peptides do not have the pair of cysteine residues
that are characteristic of deuterostomian CT-type peptides.
Interestingly, in annelids (e.g. Capitella), two genes encoding
CT-type peptides have been identified: one encoding a
CT-type peptide with two N-terminal cysteine residues and
one encoding a DH31-type peptide without two N-terminal
cysteine residues [5,8]. More recently, a second gene encoding
one or multiple CT-type peptides with two N-terminal
cysteine residues has also been identified in several arthropod
species [185]. It appears, therefore, that there was a dupli-
cation of a CT-type gene in a common ancestor of the
protostomes, with the neuropeptide product of one copy
retaining the N-terminal cysteine residues (CT-type) and
the neuropeptide product of the other copy losing the
N-terminal cysteine residues (DH31-type).
CT was first discovered in mammals as a peptide that is
released from parafollicular cells of the thyroid gland, inhibits
intestinal calcium ion (Ca2þ) absorption and inhibits osteo-
clast activity in bones [186]. CT is encoded by a gene that
also encodes CGRP, with alternative splicing giving rise to
either prepro-CT (exons 1, 2, 3 and 4) or prepro-CGRP
(exons 1, 2, 3, 5 and 6) [187]. CGRP is released by sensory
nerves and is a potent vasodilator in mammals [188]. Aside
from the diuretic actions of DH31-type peptides in insects
[184], very little is known about the physiological roles of
CT-type neuropeptides in invertebrates. With the discovery
of ArCT in A. rubens and related peptides in other echino-
derms [9,10], there are opportunities to address this issue
using echinoderms as model systems.
(a) (b)
Figure 11. Alignment of A. rubens GnRH-type peptides/precursors with other gonadotropin-releasing hormone (GnRH)-type peptides/precursors. (a) Alignment of
GnRH-type peptides. Accession numbers for the corresponding precursor proteins are: Arub, A. rubens GnRH-type precursor 1 [GenBank: KT601712]; Spur, S. pur-
puratus GnRH-type precursor 1 [GI:390361802]; Skow, S. kowalevskii GnRH-type precursor [GI:585702722]; Bflo, B. floridae GnRH-type precursor [GI:568818760];
Hsap1, H. sapiens GnRH precursor 1 [GI:133908609]; Hsap2, H. sapiens GnRH precursor 2 [GI:109731929]; Ctel, C. teleta GnRH-type precursor [GI:161294493];
Acal, A. californica GnRH-type precursor [GI:325296898]; Dmel_CORZ, D. melanogaster corazonin (CORZ) precursor [GI:386765761]; Dmel_AKH, D. melanogaster adi-
pokinetic hormone (AKH) precursor [GI:281365621]. (b) Alignment of GnRH-type precursors. Accession numbers for the corresponding precursor proteins are:
Arub_GnRH1P, A. rubens GnRH-type precursor 1 [GenBank: KT601712]; Spur_GnRH1P, S. purpuratus GnRH-type precursor 1 [GI:390361802]; Arub_GnRH2P,
A. rubens GnRH-type precursor 2 [GenBank: KT601713]; Spur_GnRH2P, S. purpuratus GnRH-type precursor 2 [GI:109403263].
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3.3.7. Precursor of two cholecystokinin-type peptides (ArCCKP)
A cholecystokinin (CCK)-type neuropeptide precursor in
A. rubens (ArCCKP) was identified as a 163-residue protein
comprising a predicted 22-residue N-terminal signal peptide
and two putative CCK-type neuropeptides bounded by
dibasic cleavage sites: RQSKVDDYGHGLFWG (ArCCK1)
and GGDDQYGFGLFFG (ArCCK2) (figure 9g; GenBank:
KT601716). The presence of C-terminal glycine residues in
both of these sequences is indicative of post-translational
modifications giving rise to a C-terminal amide group on
the mature peptides. Furthermore, an additional potential
post-translational modification for these peptides is sulfation
of the tyrosine residues (underlined above), as this is a
common characteristic of CCK-type neuropeptides in other
species [189].
CCK-type peptides have a widespread phylogenetic distri-
bution in bilaterian animals [5,6,190–192] and the antiquity of
CCK-type peptides was first revealed with the discovery of
CCK-type sulfakinin (SK) peptides in insects [193,194].
CCK-type peptides have been identified throughout the ver-
tebrates [195] and in deuterostomian invertebrates, including
the urochordate C. intestinalis [196], the hemichordate S. kowa-
levskii [5] and in the echinoderm S. purpuratus [5].
Interestingly, however, CCK-type peptides and receptors
appear to have been lost in the cephalochordate B. floridae [5].
In figure 14, we compare ArCCK1 and ArCCK2 with
CCK-type peptides identified in other species. Most ver-
tebrate CCK-type peptides typically share the conserved
C-terminal octapeptide motif DYMGWMDF-NH2, whereas
most SK-type peptides, for example in D. melanogaster, typi-
cally share the conserved C-terminal heptapeptide motif
DYGHMRF-NH2 (figure 14). ArCCKP comprises two puta-
tive CCK-type peptides with the C-terminal octapeptide
motifs DYGHGLFW-NH2 (ArCCK1) and QYGFGLFF-NH2
(ArCCK2), which share the common motif x1YGx2GLFx3-
NH2, with x3 representing a shared hydrophobic residue.
This motif shares sequence similarity with both the vertebrate
CCK-type and protostomian SK-type motifs, including the
likely presence of a conserved O-sulfated tyrosine residue
and an amidated phenylalanine residue (with the exception
of ArCCK1, which has a C-terminal tryptophan residue;
figure 14).
CCK and the related peptide hormone gastrin have a
common C-terminal tetrapeptide sequence (WMDF-NH2)
that is required for biological activity and indicative of a
common evolutionary origin [195,197,198]. CCK/gastrin-
type peptides have numerous roles in the gastrointestinal
system and central nervous system of mammals. In the
gastrointestinal system, roles in regulation of gallbladder con-
traction, gastrointestinal motility and pancreatic secretion of
digestive enzymes have been identified [199], and in the
CNS these peptides are implicated in learning and memory,
angiogenesis, nociception and regulation of food intake
[195,200–203].
SK-type peptides in insects are myotropic on the gut
[193,194,204], heart [205] and body wall muscles [206]. It
has also been discovered that SKs regulate food intake in
multiple insect species including the desert locust Schistocerca
gregaria [207], regulate digestive enzyme release in the beetle
Rhynchophorus ferrugineus [208] and the moth Opisina areno-
sella [209], and affect digestive enzyme release and fat
storage in the nematode C. elegans [191]. It appears, therefore,
that the CCK/SK-type neuropeptide system has ancient roles
in regulating physiological processes associated with feeding
and digestion. The discovery of ArCCKP in the starfish
A. rubens provides an opportunity to investigate the phy-
siological roles of CCK-type peptides in an echinoderm
species, in particular with respect to processes associated
with feeding and digestion.
3.3.8. Precursors of orexin-type peptides (ArOXP1 and ArOXP2)
An orexin (OX)-type neuropeptide precursor in A. rubens
(ArOXP1) was identified as a 112-residue protein comprising
a predicted 24-residue N-terminal signal peptide and an OX-
type peptide sequence followed by a dibasic cleavage site
(figure 9h; GenBank: KT601717). The presence of a C-term-
inal glycine residue is indicative of a post-translational
modification that gives rise to a C-terminal amide group on
the mature peptide. It is noteworthy that the putative
OX-type peptide contains six cysteine residues, which may
form up to three disulfide bridges. This contrasts with OX-
type peptides in vertebrates that have two intra-chain
disulfide bridges formed by four cysteine residues [210]. A
second OX-type neuropeptide precursor in A. rubens
(ArOXP2) was identified as a 161-residue protein comprising
a predicted 26-residue N-terminal signal peptide and an OX-
type peptide sequence, followed by a dibasic cleavage site
(figure 9i; GenBank: KT601718). As with ArOXP1, the pres-
ence of a C-terminal glycine residue is indicative of a
post-translational modification that gives rise to a C-terminal
amide group and the presence of six cysteine residues is
indicative of three disulfide bridges in the mature peptide.
OX-type peptides are a family of neuropeptides with a
widespread phylogenetic distribution indicative of an ances-
tral bilaterian origin [5,6]. Thus, OX-type peptides, despite
sharing little sequence similarity, have recently been found
to be homologous to insect allatotropin (AT)-type peptides
based on receptor orthology and precursor structure [5,6].
AT-type peptides have been identified in arthropods
[211,212] and in lophotrochozoans, including molluscs
[7,213,214] and annelids [8,215]. Interestingly, however,
AT-type peptides and receptors appear to have been lost in
nematodes and Drosophila [5,6].
In figure 15, we compare the sequences of ArOX1 and
ArOX2 with OX-type peptides that have been identified in
other deuterostomes. ArOX1 and ArOX2 are the second
members of the OX neuropeptide family to be identified in
echinoderms, following on from the identification of two
OX-type precursors in the sea urchin S. purpuratus (SpOXP1
Figure 12. Alignment of ArTRH with other thyrotropin-releasing hormone
(TRH)-type peptides. Accession numbers for the corresponding precursor proteins
are: Arub, A. rubens TRH-type precursor [GenBank: KT601714]; Spur, S. purpur-
atus TRH-type precursor [GI:109402869]; Skow, S. kowalevskii TRH-type precursor
[GI:187216047]; Bflo, B. floridae TRH-type precursor [GI:260784028]; Hsap,
H. sapiens TRH precursor [GI:485464565]; Pdum, P. dumerilii EFLGamide precur-
sor [GI:332167915].
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and SpOXP2) [5,6]. As in A. rubens, both of the OX-type pep-
tides in S. purpuratus have six cysteine residues, suggesting
the presence of three disulfide bridges in the mature peptides.
Interestingly, an OX-type peptide in the hemichordate
S. kowalevskii also has six cysteine residues [5,6] and therefore
it appears that this feature may be a characteristic of ambula-
crarian OX-type peptides. OX precursors in vertebrates
comprise two OXs termed OX-A and OX-B [216]. OX-A con-
tains four cysteine residues that form two intramolecular
disulfide bridges, whereas OX-B does not contain cysteine
residues. By way of comparison, two OX-type precursors in
the cephalochordate B. floridae comprise peptides that are
similar to vertebrate OX-A-type peptides, with four cysteine
residues, and thus this appears to be a chordate characteristic.
OXs were originally discovered as hypothalamic neuro-
peptides that stimulate food intake in mammals [210,217].
However, it has subsequently been discovered that OXs
also stimulate wakefulness and energy expenditure [218].
Similarly, OXs have also been shown to regulate feeding be-
haviour and the processes of sleep and wakefulness in teleost
fish [219]. The ATs, the protostomian homologues of OXs
[5,6], were first identified as peptides that stimulate the syn-
thesis and secretion of JH from the corpora allata in insects
[220,221]. Subsequently, other effects of ATs have been dis-
covered, including cardioacceleration and the inhibition of
active ion transport in the midgut of the tobacco hornworm
M. sexta [220–222]. Currently, nothing is known about the
physiological roles of OX-type peptides in echinoderms and
other deuterostomian invertebrates, and therefore the discov-
ery of ArOX1 and ArOX2, as reported here, provides an
exciting opportunity to now address this issue.
3.3.9. Precursor of a luqin-type neuropeptide (ArLQP)
A luqin (LQ)-type neuropeptide precursor in A. rubens
(ArLQP) was identified as a 106-residue protein comprising
a predicted 44-residue N-terminal signal peptide and a
putative LQ-type peptide sequence (EEKTRFPKFMRWG)
followed by a dibasic cleavage site (figure 9j; GenBank:
KT601719). The presence of a C-terminal glycine residue is
indicative of a post-translational modification giving rise to
a C-terminal amide group on the putative mature peptide
(EEKTRFPKFMRW-NH2).
Comparison of the LQ-type neuropeptide precursor in
A. rubens with LQ-type precursor proteins that have been
identified in other species reveals similarities (figure 16).
Thus, in A. rubens, the precursor comprises a single putative
neuropeptide (EEKTRFPKFMRW-NH2), which is also a fea-
ture of LQ-type precursors in other echinoderms (e.g. sea
urchin S. purpuratus), in the hemichordate S. kowalevskii and
in lophotrochozoans. This contrasts with precursor proteins
in the ecdysozoans comprising multiple copies of LQ-type
RYamides [6], which is probably a derived characteristic.
Another feature of the A. rubens LQ precursor is two cysteine
residues separated by a 10-residue peptide sequence in its
C-terminal region, which are also a characteristic of LQ-
type precursors in other invertebrates (figure 16). The
LQ-type neuropeptide in A. rubens has a putative C-terminal
RWamide motif, a feature that is shared by LQs in other echi-
noderms and in the hemichordate S. kowalevskii. Thus, this
appears to be a characteristic of ambulacrarian LQs, which con-
trasts with the RFamide motif of lophotrochozoan LQs and the
RYamide motif of ecdysozoan LQs (or ‘RYamides’). Compari-
son of echinoderm LQs reveals a high level of sequence
identity, with the C-terminal sequence KFMRW-NH2 a
shared feature of LQs in A. rubens, S. purpuratus (figure 16)
and A. japonicus [10].
LQ was first identified in the mollusc A. californica and
named on account of the expression of its precursor protein
in the dorsal left upper quadrant cells of the abdominal
ganglion [223]. Prior to the discovery of LQ in A. californica,
a closely related neuropeptide termed Achatina cardio-
excitatory peptide-1 or ACEP-1 was isolated from the African
giant snail Achatina fulica on account of its excitatory effect on
Figure 13. Alignment of ArCT with other calcitonin (CT)-type peptides. Accession numbers for the corresponding precursor proteins are: Arub, A. rubens CT-type
precursor [GenBank: KT601715]; Spur, S. purpuratus CT-type precursor [GI:115767208]; Skow, S. kowalevskii CT-type precursor [GI:187217193]; Bflo1, B. floridae CT-
type precursor 1 [GI:260826569]; Bflo2, B. floridae CT-type precursor 2 [GI:260826567]; Bflo3, B. floridae CT-type precursor 3 [GI:260826573]; Bflo4, B. floridae CT-
type precursor 4 [GI:260812099]; Hsap_Calc, H. sapiens CT precursor [GI:179819]; Hsap_CGRP1, H. sapiens CT gene-related peptide (CGRP) 1 precursor
[GI:269784661]; Hsap_IAPP, H. sapiens islet amyloid polypeptide (IAPP) precursor [GI:109255169]; Hsap_ADML, H. sapiens adrenomedullin precursor
[GI:675022745]; Hsap_ADM2, H. sapiens adrenomedullin 2 precursor [GI:41016725]; Ctel, C. teleta CT-type precursor [GI: 161220966]; Lgig1, L. gigantea CT-
type precursor 1 [GI:163526287]; Lgig2, L. gigantea CT-type precursor 2 [GI:676481265].
rsob.royalsocietypublishing.org
Open
Biol.6:150224
14
 on February 10, 2016http://rsob.royalsocietypublishing.org/Downloaded from 
the heart and other muscles [224]. Subsequently, a closely
related peptide termed Lymnaea cardio-excitatory peptide or
LyCEP, which also has a cardio-excitatory effect, was isolated
from the pond snail Lymnaea stagnalis [225]. More recently
LQ-type peptides have been identified in a number of lopho-
trochozoans, including other molluscs [7] and annelids [8].
Very little is currently known about the physiological roles
of the RYamides that are recognized as ecdysozoan (arthro-
pods and nematodes) homologues of LQ [5,6]. However,
evidence of a possible role in regulation of feeding behaviour
in Drosophila has been reported [226].
The discovery of LQ-type peptides in several deuterosto-
mian invertebrates [5,6,10] has revealed that the evolutionary
origin of this neuropeptide family dates back to the common
ancestor of the Bilateria. However, LQ-type peptides and
receptors have not been found in the chordates, indicating
that this neuropeptide signalling system may have been lost
in the chordate lineage. At present nothing is known about
the physiological roles of LQ-type peptides in deuterosto-
mian invertebrates and therefore the discovery of ArLQP
has provided a new opportunity to address this issue using
starfish as an experimental system.
3.3.10. Precursor of pedal peptide-type neuropeptides (ArPPLNP)
A partial 325-residue sequence of a pedal peptide (PP)-type
precursor (ArPPLNP) was identified in A. rubens, comprising
a 31-residue N-terminal signal peptide and seven putative
neuropeptides bounded by dibasic cleavage sites (figure 9k;
GenBank: KT601720). The putative peptides derived from
ArPPLNP share sequence similarity with peptides derived
from two PP-type precursors that were recently identified
in the sea urchin S. purpuratus (SpPPLNP1 and SpPPLNP2)
[9]. Furthermore, as illustrated in figure 17, representative
neuropeptides derived from ArPPLNP, SpPPLNP1 and
SpPPLNP2 share sequence similarity with PP-type peptides
in lophotrochozoans (e.g. Capitella, Lottia) and orcokinin-
type peptides in arthropods (e.g. Drosophila). Indeed, it was
the discovery of SpPPLNP1 and SpPPLNP2 in S. purpuratus
that first revealed the widespread phylogenetic distribution
and urbilaterian origin of PP/orcokinin-type peptides [9], a
finding that has been supported by subsequent studies [6].
PP was first discovered in the mollusc A. californica as a
peptide that causes contraction of pedal muscles [227,228];
it also stimulates beating of cilia associated with the foot
[229]. Orcokinin was first isolated from abdominal nerve
cord extracts of the crayfish Orconectus limosus on account
of its effect in stimulating hindgut myoactivity [230]. Orcoki-
nin-type peptides have subsequently been identified in a
number of arthropods and attributed a range of functions,
including stimulation of the prothoracic gland and regulation
of ecdysteroidogenesis in the silk moth Bombyx mori [231],
and regulation of circadian and seasonal physiology in the
cockroach Leucophaea maderae [232–234].
Currently, nothing is known about the physiological func-
tions of PP/orcokinin-type peptides in echinoderms. With
the discovery of ArPPLNP in A. rubens, as reported here, an
opportunity to address this issue in starfish has been
provided.
3.3.11. Precursors of GPA2-type and GPB5-type glycoprotein
hormones
A glycoprotein hormone a-2 (GPA2)-type precursor in
A. rubens (ArGPAP2-1) was identified as a 135-residue
protein comprising a predicted 24-residue N-terminal signal
peptide followed by a 111-residue polypeptide that shares
sequence similarity with GPA2-type subunits (figure 18a;
GenBank: KT601721). A second GPA2-type precursor
(ArGPAP2-2) was identified as a 130-residue protein com-
prising a predicted 28-residue N-terminal signal peptide
followed by a 102-residue polypeptide that shares sequence
similarity with GPA2-type subunits (figure 18b; GenBank:
KT601722). It is noteworthy that both ArGPA2-1 and
ArGPA2-2 contain 10 cysteine residues (figure 18a,b),
which, in accordance with glycoprotein hormone subunits
in other phyla, are likely to form five disulfide bridges [125].
A glycoprotein hormone b-5 (GPB5)-type precursor in
A. rubens (ArGPBP5-1) was identified as a 136-residue protein
comprising a predicted 24-residue N-terminal signal peptide
followed by a 112-residue polypeptide that shares sequence
similarity with GPB5-type subunits (figure 18c; GenBank:
KT601723). A second GPB5-type precursor (ArGPBP5-2)
was identified as a 141-residue protein comprising a pre-
dicted 31-residue N-terminal signal peptide followed by a
110-residue polypeptide that shares sequence similarity
with GPB5-type subunits (figure 18d; GenBank: KT601724).
A third GPB5-type precursor (ArGPBP5-3) was identified as
a 130-residue protein comprising a predicted 30-residue
N-terminal signal peptide followed by a 100-residue polypep-
tide sequence sharing sequence similarity with GPB5-type
subunits (figure 18e; GenBank: KT601725). It is noteworthy
that ArGPB5-1 contains eight cysteine residues while both
ArGPB5-2 and ArGPB5-3 contain 10 cysteine residues
(figure 18c–e), which are likely to form four or five disulfide
bridges, respectively, in accordance with glycoprotein
hormone subunits in other phyla [125].
Alignment of ArGPA2-1, ArGPA2-2, ArGPB5-1, ArGPB5-2
and ArGPB5-3 with glycoprotein hormones in humans and
Figure 14. Alignment of ArCCK1 and ArCCK2 with other cholecystokinin
(CCK)-type peptides. Accession numbers for the corresponding precursor pro-
teins are: Arub, A. rubens CCK-type precursor [GenBank: KT601716]; Spur, S.
purpuratus CCK-type precursor [GI:390355380]; Skow1, S. kowalevskii CCK-
type precursor 1 [GI:585688033]; Skow2, S. kowalevskii CCK-type precursor
2 [GI:187061456]; Cint, C. intestinalis cionin precursor [GI:10799472];
Hsap_CCK-8, H. sapiens CCK precursor [GI:30582820]; Hsap_Gast-6, H. sapiens
gastrin precursor [GI:47481291]; Ctel, C. teleta CCK-type precursor
[GI:161296032]; Lgig1, L. gigantea CCK-type precursor 1 [GI:161296032];
Lgig2, L. gigantea CCK-type precursor 2 [GI:52414496]; Dmel_SK, D. melanogaster
sulfakinin (SK) precursor [GI:386765036].
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Drosophila and with the related bursicon-type hormones (see
below) reveals seven conserved cysteine residues and a con-
served glycine residue. A serine or threonine residue that is
located one residue after the fourth cysteine residue in all
five of the A. rubens glycoprotein hormones is another
conserved feature (figure 19).
The glycoprotein hormones are a family of cysteine-rich
polypeptide hormones with a phylogenetic distribution
indicative of an evolutionary ancestry that dates back to the
common ancestor of the Bilateria [235]. The prototypical
members of the glycoprotein hormone family are the mam-
malian gonadotropins LH, FSH choriogonadotropin (CG)
and TSH [236]. These are heterodimeric glycoproteins com-
prising a common a-subunit and a unique b-subunit,
which is crucial for receptor specificity. The a-subunit has
10 cysteine residues forming five disulfide bridges, while
the b-subunit has 12 cysteine residues forming six disulfide
bridges, with the formation of a/b dimers necessary for
biological activity [125].
Sequencing of the human genome revealed a novel
member of the glycoprotein hormone family, which is now
known as thyrostimulin [237]. Thyrostimulin is a heterodi-
meric glycoprotein comprising an a-subunit termed GPA2
and a b-subunit termed GPB5, and it acts as a ligand for
TSH receptors [238]. GPA2- andGPB5-type subunits have sub-
sequently been identified in other vertebrates [237] and in
deuterostomian invertebrates, including urochordates
[239,240], the cephalochordate B. floridae [241], the hemichor-
date S. kowalevskii [239], and the echinoderm species
S. purpuratus [11] and A. japonicus [10]. GPA2- and GPB5-
type subunits have also been identified in ecdysozoans,
including arthropods [242] and nematodes [235], and in lopho-
trochozoans, includingmolluscs [7] and annelids [8]. Thus, the
phylogenetic distribution of GPA2- and GPB5-type subunits
indicates that these subunits have an ancestral bilaterian origin,
with the a- and b-subunits of vertebrate LH, FSH, CG and
TSH probably having evolved from GPA2- and GPB5-type
subunits, respectively, in the vertebrate lineage [243].
The physiological roles of GPA2/GPB5-type hormones in
invertebrates have yet to be characterized extensively, but it
has been shown that GPA2/GPB5-type hormones modulate
ionic and osmotic balance in insects [244,245]. To date, noth-
ing is known about the physiological roles of GPA2/GPB5-
type hormones in echinoderms. Therefore, the discovery of
glycoprotein-type hormones in A. rubens, as reported here,
provides a new opportunity to address this issue.
3.3.12. Precursors of bursicon-type hormones (ArBAP and ArBBP)
A bursicon-a-type precursor in A. rubens (ArBAP) was
identified as a 139-residue protein comprising a predic-
ted 35-residue N-terminal signal peptide followed by a
104-residue polypeptide sequence sharing sequence simi-
larity with bursicon-a-type subunits (figure 18f; GenBank:
KT601726). A bursicon-b-type precursor in A. rubens
(ArBBP) was identified as a 142-residue protein comprising
a predicted 30-residue N-terminal signal peptide followed
by a 112-residue polypeptide sequence sharing sequence
similarity with bursicon-b-type subunits (figure 18g; Gen-
Bank: KT601727). Both ArBAP and ArBBP contain 11
cysteine residues, in common with the prototypical
bursicon-type subunits in insects (figure 19).
Bursicon was originally discovered in insects on account
of its effect in causing cuticular tanning [246]. It is heterodi-
meric protein formed by two subunits, bursicon-a and
bursicon-b, which are derived from separate precursor pro-
teins [247]. Analysis of the sequences of these subunits
reveals that bursicon is a member of the glycoprotein hor-
mone family (see above). Bursicon-type subunits have been
identified in a variety of insects and in other arthropods
[248], and a role in regulation of cuticle hardening and ecdy-
sis has been demonstrated in crustaceans [249–251].
Bursicon-type subunits have also been identified in lophotro-
chozoans, including molluscs [7] and annelids [8], and in
deuterostomian invertebrates, including the echinoderm
species S. purpuratus [11], A. japonicus [10] and now
A. rubens. Thus, based on the phylogenetic distribution of
bursicons, the evolutionary origin of this peptide hormone
family dates back to the common ancestor of the Bilateria.
The physiological roles of bursicon-type hormones outside
of the arthropods are unknown. The discovery of bursicon-
type hormones in A. rubens, as reported here, provides a new
opportunity to address this issue in an echinoderm species.
3.3.13. Precursor of relaxin-like gonad-stimulating peptide
(ArRGPP)
A relaxin-like gonad-stimulating peptide precursor in
A. rubens (ArRGPP) was identified as a 109-residue protein
comprising sequentially (i) a predicted 26-residue N-terminal
signal peptide, (ii) a 20-residue polypeptide comprising two
cysteine residues (B-chain), (iii) a dibasic cleavage site,
(iv) a connecting peptide (C-peptide) domain (residues
Figure 15. Alignment of ArOX1 and ArOX2 with other orexin (OX)-type peptides. Accession numbers for the corresponding precursor proteins are: Arub1, A. rubens
OX-type precursor 1 [GenBank: KT601717]; Arub2, A. rubens OX-type precursor 2 [GenBank: KT601718]; Spur1, S. purpuratus OX-type precursor 1 [GI:346420309];
Spur2, S. purpuratus OX-type precursor 2 [GI:346419879]; Skow, S. kowalevskii OX-type precursor [GI:585662697]; Bflo1, B. floridae OX-type precursor 1
[GI:260807454]; Bflo2, B. floridae OX-type precursor 2 [GI:260780718]; Hsap_OX, H. sapiens OX precursor [GI:4557634].
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49–82), (v) a dibasic cleavage site and (vi) a 25-residue poly-
peptide comprising four cysteine residues (A-chain)
(figure 18h; GenBank: KT601728). The A-chain has the
cysteine motif CCxxx CxxxxxxxxC, which is characteristic
of the insulin/insulin-like growth factor (IGF)/relaxin super-
family (figure 20). More specifically, the final residue of the
A-chain is a cysteine, which is characteristic of the relaxin/
insulin-like (INSL) sub-class as opposed to the insulin/
IGF sub-class [252]. The B-chain has the cysteine motif
CxxxxxxxxxxxC, which is characteristic of the insulin/IGF/
relaxin superfamily (figure 20). However, the B-chain does
not contain the relaxin-specific receptor-binding motif
RxxxRxxI/V characteristic of vertebrate relaxin-like peptides
[253]. Informed by the biochemical characterization of RGP
in A. pectinifera [39], the predicted mature product of
ArRGPP is a heterodimeric protein comprising A/B-chains,
with two inter-chain disulfide bridges and an intra-chain
disulfide bridge in the A-chain.
RGPwas first identified in the starfish speciesA. pectinifera
[39] as the long-sought-after ‘gonad-stimulating substance’ or
GSS. The existence of GSS was first reported in 1959 as a com-
ponent of starfish radial nerves that triggers gamete release in
starfish [254]. Subsequently, it was characterized as a peptide
hormone [255–257], but 50 years elapsed before its molecular
identity was finally determined, revealing that it is a member
of the insulin/IGF/relaxin superfamily [39]. The existence of
GSS in many other starfish species has been reported [258].
Thus, GSS activity was first detected in extracts of A. forbesi
and early efforts to determine the chemical identity of GSS
focused onA. amurensis [258]. Recently, an RGP-like precursor
sharing a high level of sequence similarity with ArRGPP was
identified inA. amurensis, and experimental tests revealed that
synthetic A. amurensis RGP triggers gamete spawning and
oocyte maturation in this species [259]. Therefore, it is very
likely that ArRGP also triggers gamete spawning and oocyte
maturation in A. rubens.
3.3.14. Precursor of relaxin-like peptide 2 (ArRLPP2)
A second relaxin-like peptide precursor in A. rubens
(ArRLPP2) was identified as a 119-residue protein compris-
ing sequentially (i) a predicted 30-residue N-terminal signal
peptide, (ii) a 26-residue polypeptide comprising two
cysteine residues (B chain), (iii) a dibasic cleavage site, (iv)
a C-peptide domain (residues 59–91), (v) a dibasic cleavage
site and (vi) a 26-residue polypeptide comprising four
cysteine residues (A-chain) (figure 18i; GenBank:
KT601729). It is noteworthy that the N-terminal glutamine
residue in the B-chain could be subject to post-translational
conversion to a pyroglutamate. Similarly to ArRGPP (or
‘ArRLPP1’), the A-chain has the cysteine motif
CCxxxCxxxxxxxxC, while the B-chain has the cysteine motif
CxxxxxxxxxxxC characteristic of the insulin/IGF/relaxin
superfamily (figure 20). However, the B-chain does not con-
tain the relaxin-specific receptor-binding motif RxxxRxxI/V
characteristic of vertebrate relaxin-like peptides [253]. Thus,
as with ArRGPP, the predicted bioactive product of
ArRLPP2 is a relaxin-like heterodimeric protein comprising
A/B-chains, with two inter-chain disulfide bridges and an
intra-chain disulfide bridge in the A-chain.
The hormone relaxin was first identified in 1926 on
account of its softening effect on the pubic ligament [260]
and the sequence of a cDNA encoding the relaxin precursor
was reported in 1981 [261]. Subsequently, other relaxin/
INSL precursors have been identified in mammals and
other vertebrates [262,263], and the diversity of relaxin/
INSL genes in vertebrates is in part attributable to whole-
genome duplication during early vertebrate evolution
[264,265]. More specifically, it has been suggested that the
relaxin/INSL genes are products of an ancestral system that
originally consisted of three genes, two of which trace their
origins back to the invertebrates [265].
The likely physiological role of ArRGP as a regulator of
gamete maturation and spawning in A. rubens has been
discussed above. The discovery of ArRLPP2 in A. rubens pro-
vides an opportunity to investigate the physiological roles of
a second relaxin-like peptide in an echinoderm species.
3.3.15. Precursors of insulin-like growth factors (ArIGFP1 and
ArIGFP2)
ArIGFP1 is a 355-residue precursor protein comprising a
predicted 27-residue N-terminal signal peptide and A–E
domains that are characteristic of IGF-type precursors
(figure 18j; GenBank: KT601730). The B-domain contains
two cysteine residues (residues 32 and 44) and the
A-domain contains four cysteine residues (residues 91, 92,
96 and 105), which are likely to form disulfide bridges and
a peptide heterodimer between both chains based on the
presence of this feature in the insulin/IGF/relaxin superfam-
ily. ArIGFP1 has dibasic cleavage sites at the C-terminal and
N-terminal of the B-domain (residues 28–55) and A-domain
Figure 16. Alignment of ArLQ with other luqin (LQ)-type peptides and align-
ment of a conserved C-terminal domain of LQ-type precursor proteins.
Accession numbers for the corresponding precursor proteins are: Arub, A.
rubens LQ-type precursor [GenBank: KT601719]; Spur, S. purpuratus LQ-
type precursor [GI:390331828]; Skow, S. kowalevskii LQ-type precursor
[GI:585716464]; Ctel, C. teleta LQ-type precursor [GI:161280144]; Lgig, L.
gigantea LQ-type precursor [GI:163510328]; Dpul, D. pulex LQ-type precursor
[JGI:251691]; Dvir, Drosophila virilis LQ-type precursor [GI: 968114152].
Figure 17. Alignment of representative A. rubens PP/orcokinin-type peptide
with other PP/orcokinin-type peptides. Accession numbers for the correspond-
ing precursor proteins are: Arub, A. rubens PP/orcokinin-type precursor
[GenBank: KT601720]; Spur1, S. purpuratus PP/orcokinin-type precursor 1
[GI:390335272]; Spur2, S. purpuratus PP/orcokinin-type precursor 2
[GI:390352581]; Ctel, C. teleta PP-type precursor [GI:161190484]; Lgig,
L. gigantea PP-type precursor [GI:163513756]; Dmel, D. melanogaster
orcokinin precursor [GI:442624594].
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(residues 83–106), respectively, which would allow for the
removal of the intervening C-peptide (residues 58–80) as in
vertebrate insulin and relaxin. However, the ArIGFP1 A-
domain also extends to a D-domain (residues 107–133) and
E-domain (residues 134–355), a feature found in IGF-type
precursors [266].
ArIGFP2 is a 343-residue precursor protein compris-
ing a predicted 22-residue N-terminal signal peptide and
characteristic IGF-type A-, B-, C- and E-domains
(figure 18k; GenBank: KT601731). The B-domain contains
two cysteine residues (residues 28 and 40) and the
A-domain contains four cysteine residues (residues 66, 67,
71 and 80), which are likely to form disulfide bridges, and
a peptide heterodimer between both chains based on the
presence of this feature in the insulin/IGF/relaxin superfam-
ily. However, unlike vertebrate insulin and relaxin, ArIGFP2
does not have dibasic cleavage sites at the C-terminal and N-
terminal of the B-domain (residues 23–46) and A-domain
Figure 18. Precursors of cysteine-rich peptide hormones and growth factors in A. rubens. Predicted signal peptides are shown in blue, putative peptide hormones/
growth-factors are shown in red (with cysteine (C) residues underlined), C-terminal glycine (G) residues that are putative substrates for amidation are shown in
orange and putative dibasic cleavage sites are shown in green. For ArIGFP1 and ArIGFP2, the C-peptide is shown in black, the D-domain (for ArIGFP1) is shown in
olive and the E-domain is shown in maroon.
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(residues 61–81), respectively, indicating that the intervening
C-peptide (residues 47–80) is not processed for removal. Fur-
thermore, the ArIGFP2 A-domain extends to an E-domain
(residues 82–343), a feature found in IGF-type precursors [266].
Comparison of ArIGFP1/2 with IGF1/2 precursors
identified and subsequently characterized in S. purpuratus
(SpIGF1/2) [11,267] reveals that both ArIGFP1/2 and
SpIGF1/2 have an A–E domain organization, as found in
IGF-type precursors. However, ArIGFP1 and SpIGF1 are
more insulin/relaxin-like in relation to potential removal of
the C-peptide, while ArIGFP2 and SpIGF2 are more IGF-
like in relation to the C-peptide. Both the ArIGFP1/2
A-domains have the cysteine motif CCxxxCxxxxxxxxC,
characteristic of the insulin/IGF/relaxin superfamily
(figure 20). Similarly, the B-domains both have the cysteine
motif CxxxxxxxxxxxC, characteristic of the insulin/IGF/
relaxin superfamily (figure 20). Importantly, two disulfide
bridges connecting the B- and A-domains and a single
intra-disulfide bridge associated with the A-domain have
been identified in SpIGF1/2 [267]. Interestingly, it has also
been shown that SpIGF1 and SpIGF2 share more sequence
similarity with each other compared with other insulin/
IGF/relaxin superfamily members in other phyla, indicating
that they may have arisen by gene duplication in the sea
urchin or echinoderm lineage [267].
To date, the physiological function of IGF-type peptides
in non-chordate deuterostomes, and in particular echino-
derms, has not been extensively studied. It has previously
been shown that mammalian insulin stimulates growth of
the sea urchin embryo and that IGFs may be expressed in
the sea urchin larval gut [268] and adult starfish gut [269],
suggesting a role in digestive processes. Moreover, microar-
ray data confirm expression in the sea urchin embryo [270].
The identification of SpIGF1 and SpIGF2 in the sea urchin
S. purpuratus [11] has made it possible to investigate the
roles of IGFs in echinoderms. It has recently been shown
that SpIGF1 is expressed in both the stomach and intestine
of feeding larvae, with differential expression dependent on
nutrient availability, suggesting a role for SpIGF1 in digestive
processes [267]. Furthermore, it has been shown that SpIGF2
is expressed in the gastrula foregut, while the putative IGF-
type receptor (SpInsr) is expressed in the mesodermal cells
at the tip of the archenteron [267]. Taken together, this
suggests a role for SpIGF2 as a growth signal to stimulate
coelomic pouch development [267].
3.4. Discovery of SALMFamide precursors and precursors
of candidate neuropeptides in A. rubens that do
share apparent sequence similarity with known
neuropeptide families
3.4.1. Precursors of SALMFamide neuropeptides
The SALMFamide neuropeptides S1 (GFNSALMF-NH2) and
S2 (SGPYSFNSGLTF-NH2) were originally isolated from
extracts of nerves dissected from A. rubens and the closely
related starfish species A. forbesi; they were the first neuropep-
tides to be identified in an echinoderm species [21,22]. Here,
we have identified transcripts that encode the S1 and S2
precursor proteins.
The S1 precursor is a 210-residue protein comprising a
predicted 23-residue N-terminal signal peptide and, bounded
by dibasic cleavage sites, seven putative neuropeptide
sequences that have a C-terminal glycine residue, which is
a potential substrate for C-terminal amidation (figure 21a;
GenBank: KT601732). The predicted neuropeptide products
Figure 19. Alignment of glycoprotein/bursicon hormone-type precursors. Accession numbers for the corresponding precursor proteins are: Arub_GPA2_1, A. rubens
glycoprotein hormone a-2 (GPA2)-type precursor 1 [GenBank: KT601721]; Arub_GPA2_2, A. rubens GPA2-type precursor 2 [GenBank: KT601722]; Arub_GPB5_1,
A. rubens glycoprotein hormone b-5 (GPB5)-type precursor 1 [GenBank: KT601723], Arub_GPB5_2, A. rubens GPB5-type precursor 2 [GenBank: KT601724];
Arub_GPB5_3, A. rubens GPB5-type precursor 3 [GenBank: KT601725]; Arub_BursA, A. rubens bursicon-a-type precursor [GenBank: KT601726]; Arub_BursB,
A. rubens bursicon-b-type precursor [GenBank: KT601727]; Hsap_GPA2, H. sapiens GPA2 precursor [GI:189491650]; Hsap_GPB5, H. sapiens GPB5 precursor
[GI:21427593]; Hsap_FSHB, H. sapiens follicle-stimulating hormone (FSH) b-precursor [GI:124014246]; Hsap_CGB7, H. sapiens chorionic gonadotropin (CG) b-polypep-
tide 7 precursor [GI:15451749]; Hsap_LSHB, H. sapiens luteinizing hormone (LH) b-polypeptide precursor [GI:15431286]; Hsap_TSHB, H. sapiens the putative IGF-type
receptor (TSH) b-precursor [GI:47479817]; Dmel_GPA2, D. melanogaster GPA2 precursor [GI:320546230]; Dmel_TSHB, D. melanogaster glycoprotein hormone b-subunit-
related protein precursor [GI:21427595]; Dmel_BursA, D. melanogaster bursicon-a precursor [GI:665394724]; Dmel_BursB, D. melanogaster bursicon-b precursor
[GI:62392020].
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of the S1 precursor are S1 and six other putative L-type SAL-
MFamides, which like S1 have the C-terminal motif S/
TxLxF/Y-NH2 (where x is variable). Four of the novel SAL-
MFamides are octapeptides, like S1, but one peptide is one
residue shorter than S1 (LHSALPF-NH2) and another is
longer than S1 (PAGASAFHSALSY-NH2).
The S2 precursor is a 233-residue protein comprising a pre-
dicted 23-residue N-terminal signal peptide and, bounded by
dibasic cleavage sites, eight putative neuropeptide sequences
that have a C-terminal glycine residue, which is a potential
substrate for C-terminal amidation (figure 21b; GenBank:
KP330476). The predicted neuropeptide products of the S2
precursor are S2, which like S1 is an L-type SALMFamide,
and seven putative F-type SALMFamides, which have the
C-terminal motif F/YxF/Y-NH2 (where x is variable). The pre-
dicted neuropeptide products of the S2 precursor range in size
from just seven residues (AFGDFSF-NH2) to as many as 19
residues (QQSDREREVEAAQTQFYPY-NH2). Furthermore,
the N-terminal glutamine residue of the latter peptide may
be a substrate for conversion to pyroglutamate, which is a
common post-translational modification of neuropeptides.
The sequences of the S1 precursor and S2 precursor in
A. rubens are similar to those of orthologous proteins that
were recently identified in the starfish species Patiria miniata
[271]. Thus, in P. miniata, there is an L-type SALMFamide
precursor, which comprises S1 and six other L-type
SALMFamides, while an orthologue of the A. rubens S2 pre-
cursor in P. miniata comprises an S2-type peptide and eight
F-type or F-type-like SALMFamides. SALMFamide precur-
sors have also been identified in other echinoderms. As in
starfish, sea urchins (class Echinoidea; e.g. S. purpuratus),
sea cucumbers (class Holothuroidea; e.g. A. japonicus) and
brittle stars (class Ophiuroidea; e.g. Ophionotus victoriae)
have two SALMFamide precursor genes—an L-type precur-
sor and an F-type precursor. In contrast, only a single
SALMFamide gene has been identified in feather stars
(class Crinoidea; e.g. Antedon mediterranea). As crinoids are
basal to the other echinoderm classes phylogenetically, it
has been proposed that the L-type and F-type SALMFamide
precursors that occur in Asterozoa (Asteroidea and Ophiuroi-
dea) and Echinozoa (Echinoidea and Holothuroidea) may
have arisen by duplication of a gene encoding a protein
similar to the SALMFamide precursor found in extant
crinoids [272].
The physiological roles of SALMFamide neuropeptides
in echinoderms have been investigated using in vitro and
in vivo pharmacological methods. This has revealed that
both L-type and F-type SALMFamides act as muscle relax-
ants [26–28,273]. More specifically, injection of S1 or S2 in
A. rubens triggers cardiac stomach eversion, a process that
occurs naturally when starfish feed extra-orally on prey
such as mussels [26,27]. Consistent with this effect of S1
Figure 20. Alignment of insulin/relaxin/insulin-like growth factor (IGF)-type precursors. Accession numbers for the corresponding precursor proteins are: Arub_Rel1,
A. rubens relaxin-like gonad-stimulating peptide precursor [GenBank: KT601728]; Arub_Rel2, A. rubens relaxin-like peptide precursor 2 [GenBank: KT601729]; Aru-
b_IGF1, A. rubens IGF-type precursor 1 [GenBank: KT601730]; Arub_IGF2, A. rubens IGF-type precursor 2 [GenBank: KT601731]; Spur_IGF1, S. purpuratus IGF-type
precursor 1 [GI:390333650]; Spur_IGF2, S. purpuratus IGF-type precursor 2 [GI:390333648]; Skow, S. kowalevskii IGF-type precursor [GI:187064073]; Bflo1, B. floridae
IGF-type precursor 1 [JGI:72897]; Bflo2, B. floridae IGF-type precursor 2 [JGI:74371]; Bflo3, B. floridae IGF-type precursor 3 [JGI:77763]; Bflo4, B. floridae IGF-type
precursor 4 [JGI:100967]; Hsap_INS, H. sapiens insulin (INS) precursor [GI:186429]; Hsap_IGF1, H. sapiens IGF precursor [GI:49456676]; Hsap_REL1, H. sapiens
relaxin-1 precursor [GI:35932]; Hsap_REL2, H. sapiens relaxin-2 precursor [GI:35926]; Hsap_REL3, H. sapiens relaxin-3 precursor [GI:17484095]; Dmel_INSL1,
D. melanogaster insulin-like (INSL) peptide 1 precursor [GI:317423340]; Dmel_INSL2, D. melanogaster INSL peptide 2 precursor [GI:442631434]; Dmel_INSL3, D.
melanogaster INSL peptide 3 precursor [GI:221331056]; Dmel_INSL4, D. melanogaster INSL peptide 4 precursor [GI:442631435]; Dmel_INSL5, D. melanogaster
INSL peptide 5 precursor [GI:320545737]; Dmel_INSL6, D. melanogaster INSL peptide 6 precursor [GI:442614930]; Dmel_INSL7, D. melanogaster INSL peptide 7
precursor [GI:386763756]; Dmel_INSL8, D. melanogaster INSL peptide 8 precursor [GI:386771312].
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and S2 in vivo, both peptides cause dose-dependent relax-
ation of cardiac stomach preparations in vitro [27].
Furthermore, S1-immunoreactive and S2-immunoreactive
nerve fibres are present in the innervation of the cardiac
stomach, and therefore it is thought that endogenous release
of S1 and/or S2 may be responsible, at least in part, for med-
iating cardiac stomach eversion when starfish feed [24–26].
With the discovery of the sequences of the S1 and S2 pre-
cursor proteins, as reported here, we now know that both S1
and S2 are derived from precursor proteins that contain other
SALMFamides. Therefore, testing and comparing the effects
of S1 and S2 in vitro is in fact not representative of physio-
logical conditions. In the future it would be interesting to
investigate the in vitro actions of the ‘cocktail’ of SALMFa-
mides that are derived from the S1 precursor, as this will
reveal pharmacological actions that are representative of
physiological processes in vivo. Similarly, it will be interesting
to compare the effects of S2 with the effects of F-type and
F-type-like SALMFamides that are derived from the S2 precur-
sor, and to compare the effects of peptides tested individually
Figure 21. Precursors of putative neuropeptides in A. rubens that do not share apparent sequence similarity with known neuropeptide families. Predicted signal
peptides are shown in blue, putative peptides are shown in red (with cysteine (C) residues underlined), C-terminal glycine (G) residues that are putative substrates
for amidation are shown in orange and putative dibasic cleavage sites are shown in green.
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with the effects of the entire ‘cocktail’ of SALMFamides that
are derived from the S2 precursor. Experimental studies
such as these, using the starfish SALMFamides as a model
system, may provide new insights into the functional signifi-
cance of the general phenomenon of precursor proteins that
give rise to ‘cocktails’ of structurally related neuropeptides.
One important issue that remains to be resolved is the
relationship of echinoderm SALMFamide neuropeptides
with neuropeptides that have been identified in other
phyla. Insights into this issue would be gained if the recep-
tor(s) that mediate the effects of SALMFamides were
identified. Based on C-terminal sequence similarity shared
with vertebrate gonadotropin-inhibitory hormone (GnIH)/
NPFF-type neuropeptides (LxFamide) and QRFP-type neuro-
peptides (FxFamide), candidate receptors have been
proposed [274]. However, definitive identification of SAL-
MFamide receptors will require functional expression
studies and the neural transcriptome sequence data that we
have obtained for A. rubens provides a basis for this.
3.4.2. Precursor of AN peptides (ArANPP)
ArANPP is a 274-residue precursor protein comprising a pre-
dicted 24-residue N-terminal signal peptide and six putative
neuropeptides with an N-terminal alanine (A)/asparagine
(N) (AN) motif, which are bounded by putative dibasic clea-
vage sites (figure 21c; GenBank: KT601733). Three of the
predicted neuropeptides have a C-terminal glycine residue,
which may be a substrate for post-translational conversion
to an amide group. ArANPP was identified on account of
its sequence similarity with the sea urchin AN peptide
precursor SpANPP [9].
The AN peptides are a family of peptides that have to
date only been identified in the echinoderms [9,10], and a
relationship with neuropeptides identified in other phyla
has yet to be determined. Some similarities with TK-type
peptides have been noted [10], but with the discovery of
other TK-type peptides in A. rubens (see above), it would
appear that these similarities may be due to convergence.
The physiological roles of AN peptides in echinoderms are
unknown so the discovery of ArANPP has provided an
opportunity to address this issue using the starfish
A. rubens as a model experimental system.
3.4.3. Arnp11
Arnp11 was identified and named on account of its similarity
with Spnp11, a putative neuropeptide precursor in the sea
urchin S. purpuratus [9]. It is a 103-residue precursor protein
comprising a 21-residue N-terminal signal peptide followed
by an 82-residue polypeptide sequence (residues 22–103)
that contains a putative dibasic cleavage site at residues 45/
46 (figure 21d; GenBank: KT601734). The N-terminal region
of the protein (residues 22–44) contains six acidic residues
(D or E), which indicates that this part of the protein
may be an acidic spacer peptide. We propose that it is the
57-residue polypeptide formed by residues 47–103 that
may be a secreted bioactive neuropeptide. It is noteworthy
that the 57-residue polypeptide includes six cysteine residues,
which may form up to three intramolecular disulfide bridges.
Alternatively, a homodimeric protein could be formed by up
to six intermolecular disulfide bridges.
The putative 57-residue polypeptide (Arn11) derived
from Arnp11 shares sequence similarity with a putative 54-
residue polypeptide (Spn11) derived from Spnp11, including
the presence of six cysteine residues. However, these poly-
peptides do not share any apparent sequence similarity
with neuropeptides or peptide hormones that have been
identified in any other phyla. Nevertheless, neuropeptides
of a similar size and with six cysteine residues have
been identified in other animals. For example, eclosion hor-
mone in insects [275] and a family of peptide hormones in
crustaceans comprising molt-inhibiting hormone, vitellogen-
esis-inhibiting hormone and crustacean hyperglycaemic
hormone [276–278] each comprise six cysteine residues that
form three intramolecular disulfide bridges.
3.4.4. Arnp15a and Arnp15b
Arnp15a and Arnp15b were identified and named on account
of their similarity to Spnp15, a putative neuropeptide
precursor in the sea urchin S. purpuratus [9].
Arnp15a is a 111-residue protein comprising a predicted
19-residue N-terminal signal peptide followed by a 92-residue
polypeptide sequence (residues 20–111) that contains a diba-
sic cleavage site at residues 54/55 (figure 21e; GenBank:
KT601735). The N-terminal region of the protein (residues
20–53) contains eight acidic residues (D or E), indicating
that this part of the protein is an acidic spacer peptide. We
propose that it is the 53-residue polypeptide formed by
residues 56–108 that may be a secreted bioactive neuropep-
tide. The presence of six cysteine residues in the 53-residue
polypeptide suggests that there may be up to three intramole-
cular disulfide bridges. Alternatively, a homodimeric protein
could be formed by up to six intermolecular disulfide bridges.
Arnp15b is a 111-residue protein comprising a predicted
25-residue N-terminal signal peptide followed by an 86-resi-
due polypeptide sequence (residues 26–111) that contains a
dibasic cleavage site at residues 63/64 (figure 21f; GenBank:
KT601736). The N-terminal region of the protein (residues
26–62) contains six acidic residues (D or E), indicating that
this part of the protein may be an acidic spacer peptide. We
propose that it is the 47-residue polypeptide formed by resi-
dues 65–111 that may be a secreted bioactive neuropeptide.
The presence of six cysteine residues in the 47-residue
polypeptide suggests that there may be up to three intramole-
cular disulfide bridges. Alternatively, a homodimeric protein
could be formed by up to six intermolecular disulfide bridges.
3.4.5. Arnp18
Arnp18 was identified and named on account of its similarity
to Spnp18, a putative neuropeptide precursor in the sea
urchin S. purpuratus [9]. Arnp18 is a 113-residue protein com-
prising a predicted 27-residue N-terminal signal peptide
followed by an 86-residue polypeptide sequence (residues
28–113) that contains a putative dibasic cleavage site at resi-
dues 36/37 (figure 21g; GenBank: KT601737). We propose
that it is the 76-residue polypeptide formed by residues 38–
113 that may be a secreted bioactive neuropeptide (Arn18).
It is noteworthy that Arn18 contains nine cysteine residues,
which may form up to four intramolecular disulfide bridges.
Alternatively, a homodimeric protein could be formed by up
to nine intermolecular disulfide bridges. Arn18 and Spn18 do
not share any apparent sequence similarity with
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neuropeptides or peptide hormones identified in any other
phyla. However, neuropeptides similar in size comprising
eight cysteine residues have been identified in other animals;
for example, the anti-gonadotropic peptide schistosomin in
the pond snail L. stagnalis, which is thought to have four
intramolecular disulfide bridges [279].
3.4.6. Arnp21
Arnp21 is a 102-residue protein comprising a predicted
22-residue N-terminal signal peptide followed by an
80-residue polypeptide sequence (residues 23–102) that con-
tains putative dibasic cleavage sites at residues 45/46 and
67/68 (figure 21h; GenBank: KT601738). We propose that it
is the 22-residue peptide formed by residues 23–44 (Arn21a)
and the 20-residue peptide formed by residues 47–66
(Arn21b) that may be secreted bioactive neuropeptides. The
presence of C-terminal glycine residues on both of these pep-
tides is indicative of post-translational modifications giving
rise to a C-terminal amide group on the mature peptides.
3.4.7. Arnp22
Arnp22 is a 157-residue protein comprising a predicted 24-
residue N-terminal signal peptide followed by a 133-residue
polypeptide sequence (residues 25–157) that contains puta-
tive dibasic cleavage sites at residues 86/87, 112/113, 126/
127, 136/137 and 151/152 (figure 21i; GenBank: KT601739).
We propose that it is the 24-residue polypeptide formed by
residues 88–111 (Arn22a) and the 23-residue polypeptide
formed between residues 128–150 (Arn22b) that may form
secreted bioactive neuropeptides. It is noteworthy that both
Arn22a and Arn22b contain two cysteine residues that are
separated by four amino acid residues and that may form
intramolecular disulfide bridges. Alternatively, heterodimeric
polypeptides could be formed by up to two intermolecular
disulfide bridges. It is also noteworthy that both Arn22a
and Arn22b have the same C-terminal pentapeptide
sequence—NQRGW. Therefore, this conserved feature may
be critical for the bioactivity of the candidate neuropeptides
derived from Arnp22.
3.4.8. Arnp23
Arnp23 is a 118-residue protein comprising a predicted
24-residue N-terminal signal peptide followed by a
94-residue polypeptide sequence (residues 25–118) that con-
tains putative dibasic cleavage sites at residues 51/52, 75/76
and 111/112 (figure 21j; GenBank: KT601740). We propose
that it is the 22-residue polypeptide formed by residues
53–74 (Arn23a) and the 34-residue polypeptide formedby resi-
dues 77–110 (Arn23b) that may form secreted bioactive
neuropeptides. It is noteworthy that both Arn23a and Arn23b
contain two cysteine residues that are separated by four
amino acid residues and that may form intramolecular disul-
fide bridges. Alternatively, a heterodimeric protein could be
formed by up to two intermolecular disulfide bridges. Interest-
ingly, both Arn23a and Arn23b have the same C-terminal
tripeptide sequence (RGW), which, as highlighted above, is a
feature of Arn22a and Arn22b. This suggests that Arnp22 and
Arnp23 may be related and, as with Arnp22, the conserved
RGW motif may be critical for the bioactivity of the candidate
neuropeptides derived from Arnp23.
3.4.9. Arnp24
Arnp24 is an 83-residue protein comprising a predic-
ted 16-residue N-terminal signal peptide followed by a
67-residue polypeptide sequence (residues 17–83) that con-
tains putative dibasic cleavage sites at residues 60/61 and
76/77 (figure 21k; GenBank: KT601741). We propose that it
is the 14-residue peptide formed by residues 62–75 that
may form a secreted bioactive neuropeptide. The presence
of a C-terminal glycine residue on the peptide is indicative
of post-translational modification giving rise to a C-terminal
amide group on the mature peptide. The putative neuro-
peptide (Arn24) contains two cysteine residues, which may
form an intramolecular disulfide bridge. Alternatively, a
homodimeric protein could be formed by up to two intermo-
lecular disulfide bridges. Finally, it is noteworthy that the
position of Arn24 in the C-terminal region of the precursor
and the presence of two cysteine residues is reminiscent of
SS/MCH-type neuropeptides (see above), which may pro-
vide clues towards functional characterization of Arn24 as a
putative neuropeptide.
3.4.10. Arnp25
Arnp25 is a 97-residue protein comprising a predicted 31-
residue N-terminal signal peptide followed by a 66-residue
polypeptide sequence (residues 32–97) that contains a puta-
tive dibasic cleavage site at residues 46/47 (figure 21l;
GenBank: KT601742). We propose that it is the 14-residue
peptide formed by residues 32–45 that may form a secreted
bioactive neuropeptide. The presence of a C-terminal glycine
residue on the peptide is indicative of post-translational
modification giving rise to a C-terminal amide group on
the mature peptide. It is also noteworthy that the putative
neuropeptide (Arn25) contains two cysteine residues, which
may form an intramolecular disulfide bridge. Alternatively,
a homodimeric protein could be formed by up to two inter-
molecular disulfide bridges. It should also be noted that the
two arginine residues preceding the first cysteine residue rep-
resent a potential dibasic cleavage site. If this were indeed a
cleavage site then the putative neuropeptide Arn25 would
be an 11-residue peptide and not a 14-residue peptide. Inter-
estingly, Arnp25 shares some similarities with VP/OT-type
neuropeptide precursors—the putative neuropeptide Arn25
is located proximal to the N-terminal signal peptide and, in
common with VP/OT-type peptides, Arn25 is a putative
C-terminally amidated peptide with two cysteine residues
separated by four amino acid residues. These shared charac-
teristics may, of course, have arisen by convergent evolution.
Nevertheless, Arn25 represents an interesting candidate
neuropeptide for further investigation.
4. Conclusions
The identification of 40 neuropeptide precursors in the starfish
A. rubens has provided important new insights into the evol-
ution and diversity of neuropeptide signalling systems. Most
noteworthy are the discovery of the first kisspeptin (KP)-
type and MCH-type precursor proteins to be identified in a
non-chordate species. Other neuropeptide families that
have been identified previously in protostomes and deuteros-
tomes have been identified here for the first time in an
ambulacrarian/echinoderm species including tachykinin
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(TK)-, somatostatin (ss)-, PDF- and CRH-type precursor pro-
teins. However, it should be noted that assignment of
neuropeptides as members of bilaterian neuropeptide families
based solely on sequence data can be difficult because of
sequence convergence or divergence. More definitive proof
of relationships can be obtained by identification of the cog-
nate receptors for neuropeptides [5], and this will be an
important objective for future research on the candidate neuro-
peptides identified here. Furthermore, mass spectroscopic
identification of the mature neuropeptides derived from the
starfish neuropeptide precursors identified here will be an
important prelude to their functional characterization.
This study provides the most comprehensive identifi-
cation of neuropeptide precursors in an echinoderm, in
comparison with our previous analyses of transcriptome
sequence data from the sea urchin S. purpuratus and the sea
cucumber A. japonicus [9,10]. Discovery of 40 neuropeptide
precursors in A. rubens provides a rich resource that estab-
lishes this echinoderm species as a model system for
neuropeptide research, building upon pioneering research
that enabled the discovery and functional characterization
of the first neuropeptides to be identified in echinoderms—
the SALMFamide neuropeptides S1 and S2 [29]. Furthermore,
functional characterization of neuropeptides facilitated by
analysis A. rubens neural transcriptome sequence data has
already commenced. Thus, identification of the precursor of
the neuropeptide NGFFYamide in A. rubens enabled func-
tional characterization of this neuropeptide as a neural
regulator of cardiac stomach contraction and retraction in
starfish [156]. Likewise, experimental studies directed
towards functional characterization of other candidate neuro-
peptides identified here are ongoing. We anticipate that
discovery of the physiological roles of starfish representatives
of ancient bilaterian neuropeptide families will provide
important new insights into the evolution of neuropeptide
function in the animal kingdom, particularly in the context
of a pentaradial bauplan, which is such a unique and fasci-
nating characteristic of starfish and other echinoderms.
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